



PREDICTORS OF HEALTHCARE OUTCOMES AT THE LOCAL 
COMMUNITY LEVEL: VARIATIONS IN THE VALUE OF 
HEALTHCARE SERVICES UNDER KOREA’S UNIVERSAL 








A dissertation submitted to Johns Hopkins University in conformity with the 










Objectives: To determine the possible relationship between the premature death 
and national health insurance (NHI) healthcare services expenditures (HE) at the 
local community level, and possible local determinants of health that might affect 
the variation in premature deaths among 231 local communities (n=231).  
 
Methods: Based on the simplified Local Determinants of Health (LDH) 
framework, a value of HE model for local healthcare services (HS) was designed, 
and the following health outcome variables were defined: Years of Potential Life 
Lost before age 75 (YPLL-75) of all premature deaths and YPLL-75s of premature 
deaths due to Cancers and Suicide in 231 local communities.  The incremental 
Value of HS models and Multiple Linear Regression (MLR) models (n = 231 local 
communities) for all NHI HS as well as healthcare services for cancers and 
mental health problems were constructed to determine the relationships between 
the averted YPLLs (the dependent variables) and the changes of NHI HE (the 
main independent variable) between 2007 and 2012 at the local community level.  
In the MLR models, 16 independent variables were included in order to 




Results: Overall, the recently increased NHI HE at the local community level 
was associated with a decrease of premature deaths under the Korean NHI 
system.  But the regional variations in the values of HS were somewhat large.  
Specifically, when the various determinants of health were considered and 
controlled in the MLR model, the influences of the NHI HE increases on the 
health outcomes (the averted YPLLs) were very limited.  More specifically it was 
found that in the important healthcare service areas like cancer care and mental 
health care, the values of HS showed negative ratios and diminishing trends as 
the NHI HE increased among communities. Regardless of NHI HE’s increases, 
certain determinants of health including some biological and behavioral factors, 
affected the health outcomes directly and modified the values of NHI HE as well. 
Conclusions: Improving the biological and behavioral health status and targeted 
health policies for low health performance areas are important to improve the 
health outcomes in terms of YPLLs and the value of NHI HE in Korea.  
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Chapter 1: Introduction 
 
1.1. Problem Statement 
Recently, the world economy is experiencing slower growth and severe 
fiscal constraints, and these constraints are leading to the decreasing health 
expenditures globally as seen in Figure 1 (OECD, 2012).  In this situation, policy 
makers are requesting higher value to be demonstrated by public services, and 
the health care sector is not an exception.  To provide some evidence and policy 
priorities on how to ensure higher value of health care services and health 
expenditures in the national health policy perspective, country specific studies 
on the health related factors that produce better health outcomes under given 
health expenditure levels should be highlighted. 
In South Korea, the national health insurance (NHI) system has been 
expanding its coverage continuously and the total health care expenditure for 
NHI covered services has increased about 2.5 times from 18.8 trillion KRW (1$ = 
1,060 KRW) in 2002 to 46.2 trillion KRW in 2011.  In spite of the difficult global 
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economy, Korea has also shown the fastest annual growth rate in health 
spending across the OECD countries (OECD, 2012).  (Figures 2 & 3) 
Especially, starting from 2005, the Korean government has expanded NHI 
coverage aggressively with their long term plan.  But their NHI coverage 
expansion has focused on the health care services for 4 severe diseases including 
cancer, cardiovascular, cerebrovascular, and rare diseases.  Starting in 2009, the 
coverage of services for 4 severe diseases has been expanded very aggressively 
again as the special coverage exception plan.  In 2009, the out of pocket 
coinsurance rate for cancer treatment decreased from 10% to 5 % and for 
treatment of 138 rare diseases from 20% to 10%.  In 2010, the coinsurance rate for 
cardiovascular and cerebrovascular disease treatment was lowered from 10% to 
5% as well.  During 2009 and 2011, many high-priced medicines and operations 
for cancer treatments were also newly included in the NHI coverage. (Table 1-1) 
Actually, since cancer is recognized as the No. 1 cause of death in South 
Korea, and considering the socio-economic impacts on families as well as 
patients due to the high burden for cancer treatment, the Korean government has 
increased their NHI coverage of cancer care as a top priority.  The total 
expenditure for NHI covered cancer treatments has increased 3.9 times from 1.0 
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trillion KRW in 2002 to 3.9 trillion KRW in 2011 which is 56% higher than the 
overall health expenditure growth rate during the same period in Korea.  But 
these recent NHI coverage reforms have not been evaluated in terms of health 
outcomes including averting premature death and the value of health 
expenditures.   
Now the Korean government recognizes that they need some policy 
measures to improve the efficiency or the value of NHI Health Services in terms 
of value for money considering the fiscal constraints and limited financial 
resources.  But the studies on the value of NHI Health Services and the health 
related predictors that lead to better health outcomes have not been fully 
addressed in Korea in terms of public health policy perspectives. 
Moreover, another important aspect of Korean society to consider in 
health policy is the problem of the rapid aging population due to the extremely 
low fertility rate1 since the 1990’s. (Table 1-3)  While promoting a higher fertility 
rate is very important, decreasing mortality, specifically lowering premature 
                                                          
1
  The fertility rate decreased from 2.06 in 1983 to 1.19 in 2013 and the percentage of the over 65 
population to the total population increased from 5.1% in 1990 to 12.2% in 2013. 
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death, should be a top priority and should be considered one of the most 
important health outcomes in Korean health care policy in the future. 
 
1.2. Study Aims  
Considering these health care policy needs in Korea, this study will focus 
on how to measure and how to improve the efficiency or the value of NHI 
Health Services at the local community level in terms of the health outcome of 
lowering premature death.  Specifically, this study will examine if “recent NHI 
Health Expenditure growth has contributed to lowering premature death”, and 
“which health determinants have facilitated the NHI’s contribution to better 
health outcomes” at the local community level. 
Assuming that the value of healthcare services at the local community 
level can be different due to the differences in health-related factors like various 
material circumstances, behavioral health factors, regional health prevention, 
health care service utilization, and health care resources, a broader study on 
determinants of health outcomes at the local community level would be needed 
to define major predictors which will facilitate the higher value of health services 
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in Korea.  Therefore, this study starts from the question of why there have been 
health outcome and efficiency gaps among different local communities in terms 
of premature death even in a country in which local communities are under the 
same universal NHI system like in South Korea.   
To compare communities and analyze the variations of premature death, 
this study will focus on comparing the value of NHI Health Services (HS) overall 
and for cancer and mental health at the local community level since these are 
considered among the leading causes of deaths2 and their associated burdens in 
terms of premature deaths in Korea. 
Although the introduction of new treatment technologies and medicines is 
important to improve overall health outcomes, healthy life styles and behaviors, 
good preventive care, and effective health care systems might be more important 
under the given health technology and expenditure levels.  
In this regard, this study aims to evaluate the effects of various possible 
health determinants on the value of NHI HS at the local community level, and to 
develop a value of HS model based on certain relationships between health 
                                                          
2
  Especially in Korea, the suicide rate is a big problem compared with other countries.  Among OECD 
countries, the suicide rate in Korea has been the highest for more than 10 years, and the rate in 2012 is 
29.1 per 100,000 persons compared with the OECD average, 12.1. 
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determinants and the value of NHI HS at the local community level.  Although 
there are many socio-economic dimensions and regional characteristics that 
might affect the value of local HS in Korea, this study will consider broader 
health related factors representing life styles and health environments, health 
promotion and prevention, health resources, and health utilization within a 
social determinants of health perspective. 
In South Korea there are 16 provinces including 7 metropolitan cities, and 
under these provinces, there are 230 municipal regions including 143 cities and 
87 towns3.  Among these regions, the different levels of indicators related to 
health promotion and prevention can be recognized to result in some of the 
variations of local health outcomes.  Moreover, it is assumed that more efforts on 
better life styles, better health environments, better preventive care, better 
coordination of services, and better health resource allocation at the local 
community level would be desirable to promote better regional health outcomes 
under the given level of health expenditures in the Korean NHI system. 
In this context, this study has two specific objectives as follows:   
                                                          
3 If Cheju special province is included as a community region for analytical purposes, the 
total number is 231. 
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1) This study will analyze the values of NHI HS in the 231 local 
communities in terms of lowering premature death and compare the 
variation among different cities and towns.   
2) This study will analyze the possible local determinants of health that 
might affect the variation of the values of HS among 231 local 
communities (n=231).  This analysis will determine which health 
related factors might influence less premature death or higher value 
of NHI HS at the local community level.  Basically health 
determinants will include indicators of health circumstances, health 
behaviors and prevention like smoking control, and health care 
resources and utilization like the number of physicians (specialists), 
and hospital beds. 
These objectives assume that we can develop a Value of HS model in terms 
of premature death at the local community level in Korea and evaluate the local 
Health Care Values which will be different among the local communities, 
including different cities and towns.  The health care policy perspective also 
supposes that the Value of healthcare services can be increased in cases where 
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other health circumstances and resource allocations in the local communities are 
improved. 
South Korea also can provide a very good study population to analyze 
many of the predictors that affect the variations of health outcomes at the local 
community level since it has the universal national health insurance system (NHI) 
and a single ethnicity in all communities.  This will be helpful to control possible 











Figure 2. Average Annual Growth in Health Spending across OECD Countries 













Table 1-1. NHI Policy Structure for NHI covered services 
 
Benefit Categories 
Korean NHI Coverage Structure 
2007 2008 2009 2010~ 








40% (Rural 35%) 







Cancer 10% (In/Out) 5% (In/Out) 
Rare Diseases 20%(In/Out) 10% (In/Out) 
Heart Disease & 
Cerebrovascular 
Disease 
10% (In/Out) 5% 
Under 6 
age 
Out 70% of Adult Co-Insurance 
In 0% 10% (New born 0%) 
*Co-payment 
Ceiling 
Low Income (50%) 
2,000,000 KRW 
(6 month) 
2,000,000 (1 year) 
Middle Income 
(30%) 
3,000,000 (1 year) 
High Income (20%) 4,000,000 (1 year) 




Table 1-2.  Leading Causes of death in Korea (2001~2011) 
 
 
  (Source: Korea National Statistics Office, 2012) 
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Table1-3. Population Change in Korea (Source: UN statistics) 











CBR1 CDR1 NC1 TFR1 IMR1
1950-1955 722 000 331 000 391 000 35.8 16.4 19.4 5.05 138
1955-1960 1 049 000 356 000 693 000 45.4 15.4 30 6.33 114.4
1960-1965 1 067 000 347 000 720 000 39.9 13 27 5.63 89.7
1965-1970 985 000 298 000 687 000 32.9 9.9 23 4.71 64.2
1970-1975 1 004 000 259 000 746 000 30.4 7.8 22.5 4.28 38.1
1975-1980 833 000 253 000 581 000 23.1 7 16.1 2.92 33.2
1980-1985 795 000 248 000 547 000 20.4 6.4 14 2.23 24.6
1985-1990 647 000 239 000 407 000 15.5 5.7 9.8 1.6 14.9
1990-1995 702 000 239 000 463 000 16 5.5 10.6 1.7 9.7
1995-2000 615 000 247 000 368 000 13.6 5.5 8.1 1.51 6.6
2000-2005 476 000 245 000 231 000 10.2 5.3 5 1.22 5.3
2005-2010 477 000 243 000 234 000 10 5.1 4.9 1.29 3.8
1 CBR = crude birth rate (per 1000); CDR = crude death rate (per 1000); NC = natural change (per 1000); TFR = total fertility rate (number of children per woman); 









Chapter 2: Literature Review4 
 
2.1. Assessment of Korea’s NHI & Health care system 
Historically, Korea has been a good example of a country showing a 
positive relationship between economic development and the length and quality 
of life. (Sen, 1999)  Life expectancy at birth has increased from just 62.3 years in 
1972 to 81.3 years in 2012.  The demographic transition in Korea has been 
ongoing since the beginning of the 1960s, mainly due to the rapid socioeconomic 
development including public health and the health care system. 
The ongoing instruments to finance healthcare services in Korea are 
composed of the National Health Insurance System (‘NHI’ hereafter) funded by 
mandatory social insurance contributions and the Medical Aid Program (MAP) 
financed by a government budget for the poor as a Livelihood Protection 
Program.  Currently, approximately 97 percent of the Korean population is 
                                                          
4
  For the literature review, comparative studies on regional variations and disparities of health 
outcomes, and health economics and studies of determinants of premature death and burden of disease 




covered by NHI operated by the NHI Corporation (‘NHIC’ hereafter), and the 
remaining 3 percent by MAP.  
Under the oversight of the Ministry of Health and Welfare (MOHW), NHIC 
is responsible for administering the NHI program including management of the 
eligibility qualifications of the insured and their dependents, collections of 
contributions, setting of medical fee schedules through negotiation with 
providers, provision of health insurance benefits through payments for medical 
services rendered to the insured, and the operation of other health-related 
projects such as health promotion and prevention activities. 
At this point, only 63% of total medical care costs are reimbursed by the 
NHIC based on fee-for-service payments with a co-insurance payment structure 
controlled by the government, while 21% of medical costs are paid by patients in 
the form of coinsurance and copayments for the medical services covered by 
NHI and 16% of medical care costs are paid out of pocket for uncovered services 
like private rooms.   
In the case of health care services for 4 severe disease categories, including 
cancer, heart, cerebrovascular, and rare diseases, the Korean government has 
recently increased the rate of NHI reimbursement to over 90% as we discussed 
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previously.  However, only 76.1% of total health care costs for the 4 severe 
disease categories are reimbursed by the NHIC due to the increase in uncovered 
cancer care services (NHIC, 2012).  According to a recent study done by the 
NHIC in 2012, 11.6 trillion KRW was funded for newly expanded coverage from 
2005 to 2010, and 25.8% of this was used for the coverage expansion of cancer 
treatment (Lee at al., 2012).  Also according to the recent NHIC annual survey of 
the NHI coverage rate of total treatment costs, the average coverage rate for all 
treatments is 63.0%, while the average coverage rate for treatments of the 4 
severe disease categories is 76.1% (NHIC, 2013).  Many health experts have also 
pointed out that the recent NHI has focused too much on the 4 severe diseases 
like cancers, and these NHI policies have produced inequalities with other major 
causes of death and important diseases like other chronic diseases including 
hypertension and diabetes (Yoon, 2013).  
The other health insurance administrative wing of MOHW, the Health 
Insurance Review and Assessment Service (HIRA), is in charge of reviewing 
claims transferred from health care organizations and evaluating the 
appropriateness of health care services provided to patients.  In addition to 
reviewing and evaluating health care services, HIRA establishes and revises the 
standards of health care and fee schedules, implements quality improvement 
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initiatives for health care services, and conducts various health care research 
studies with regard to utilization, appropriateness, and comprehensive care 
management. 
All health care organizations submit their claims to HIRA mainly through 
the NHI Electronic Data Interface (EDI) system.  After completing its review, 
HIRA sends the reviewed results to NHIC.  NHIC pays claims based on the 
results reviewed by HIRA. 
Although the NHI has a single payment claim system under the control of 
the Health Insurance Review and Assessment Service (HIRA) to review 
inappropriate medical fee claims, there still may be a high possibility for medical 
care institutions to provide overuse of drugs and treatments, and claim 
overpayments in order to maximize their revenues under the NHI’s fee-for-
service payment system, and these claim problems might vary by region 
regardless of health outcomes.  (Figure 5) 
Even though Korea has a single universal healthcare insurance system in all 
regions, there have been many debates on the variations in total healthcare 
expenditures, access to care, health care resources, and health promotion at the 
local community level, resulting in possible health disparities and inequities 
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among communities.  For example, according to a recent report by the Ministry 
of Health and Welfare, the life expectancies at birth in 16 local provinces were 
analyzed in a 2010 local health level study and the life expectancy gap between 
the highest and lowest provinces was about 3.55 years for men and 3.49 for 
women.   
Recently, the regional health variations and inequity issues in Korea have 
also been recognized as one of the very important socio-economic issues, and it is 
considered that there may be some variations in the regional health outcomes 
that might be explained by various regional health determinants.   
For example, in the case of the cancer care outcomes in South Korea, the 
deaths due to stomach cancer decreased from 10,134 (age standardized rate per 
100,000 persons: 17.4) in 2009 to 10,031 (16.5) in 2010, and the deaths due to 
colorectal cancer increased from 7,105 (12.1) in 2009 to 7,701 (12.5) in 2010.  In the 
case of incidence cases, the stomach cancer cases increased from 29,727 (age 
standardized rate: 44.8) to 30,092 (43.5) in 2010, and the colorectal cases increased 
from 24,986 (37.3) in 2009 to 25,782 (36.9) in 2010 overall. (NCIC, 2012)5   
                                                          
5 But the age standardized incidence rate decreased due to the continuous increase of over 
65 age population from 7.2% in 2000 to 11.3% in 2010.  The crude cancer incidence rate of over 
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Overall, it can be assessed that the cancer care outcomes have been 
improved, but if we see the cancer mortalities by communities, we can find 
somewhat big variations of mortalities among communities. (Figure 6 & 7)  
Especially, according to the stomach cancer mortality rate data of each 
community from the National Statistics Office’s cause of death database, and the 
smoking and high BMI population rates of each community collected from the 
MOHW’s annual regional health level survey database, there was a positive 
relationship between the population smoking rate and the stomach cancer age-
standardized mortality rates among 231 local communities in 2010. (Figure 6)  
Also there was a positive relationship between high BMI population rates and 
stomach cancer mortality rates. (Figure 7)  From this, we can guess that different 
levels of behavioral and biological factors in the local communities might result 
in different levels of health outcomes in Korea.  
 Moreover, many experts have pointed out that if the Korean government 
effectively utilizes the NHI’s health care data and personal health information, 
including medical statuses and histories, 5.5 to 8.2 trillion KRW could be saved 
since the big-data revolution in health care can make our health care system 
                                                                                                                                                                             
65 people in 2010 was 1559.5 per 100,000, which was almost 3 times higher than the rate of 
people who were 35 to 64 years of age (489.2). (NCIC, 2012) 
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2.2. Predictors of Health Care Outcomes 
Today improving health is recognized as a very important socio-economic 
development objective, and there is a growing consensus that improving health 
can have a large effect on national socio-economic growth and development.   
According to a WHO report in 2001, improving crucial health care services 
can reduce poverty, and promote economic development and growth.  A cross-
country level study on life expectancy in 2000 also found that life expectancy is 
positively correlated to GNP per capita, population growth, fertility, enrollment, 
and access to safe water, and life expectancy is negatively correlated to AIDS, 
tuberculosis, and rate of deforestation.  This study showed that life expectancy is 
meaningfully determined by economic factors, sanitation, and certain disease 
prevalence (Chen & Ching, 2000).   
Although many cross-country level studies have shown strong 
relationships between life expectancy, reflecting the overall health outcome of a 
nation’s citizens, and economic development and growth at the macro-level 
including the population increase effect, the causal relationship between them 




Cross-country level comparisons of predictors of better health outcomes 
have also been debated among public health researchers.  According to OECD 
life expectancy studies, the U.S has shown lower scores compared with other 
developed countries like Japan and Sweden.  Lower life expectancy in the U.S 
has provided the main reason to blame the poor health performance of the U.S. 
health care system in spite of the highest health care expenditure level in the 
world.   
But considering the fact that the mortality rate from many factors including 
car accidents and homicides might affect life expectancy a lot, the comparison of 
life expectancy at the cross-country level cannot exactly tell us which country has 
a better health care system.  Moreover, since healthcare insurance systems 
including private and public, ethnicities, cultures, and even education systems 
are different from each other among countries, comparing health outcomes 
directly at the cross-country level might have big limitations.   
In fact, without the deaths from fatal injuries like car accidents and 
homicides which are not much related to health care service quality, the life 
expectancy in the U.S was analyzed with results suggesting that the mean score 
might rank first in the world. (Roy, 2011)  Preston and Ho also pointed out in 
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their recent study in 2009 that the U.S has shown significantly faster declines in 
mortality from prostate cancer and breast cancer than comparison countries, and 
they concluded that the low life expectancy ranking of the U.S does not seem to 
be a result of a poorly functioning health care system. (Preston and Ho, 2009)   
The recent study on the 2010 global burden of disease (GBD) led by WHO 
in 2012 also pointed out that global disease patterns affecting mortalities and 
disabilities are very different by regions and countries, and to obtain public 
health policy implications, studies on different risk factors by regions and 
countries also should be addressed more in the future. (Murray at al., 2012) 
In this context, to obtain useful and robust policy evidence to determine 
predictors and risk factors that affect the variations of health outcomes like life 
expectancy, mortality rates, and QALYs (Quality Adjusted Life Years), country 
specific comparative studies should be highlighted.  Since health outcomes can 
be affected by many different socio-economic factors like ethnicity, natural 
environments, dietary culture, the education system, health expenditures, and 
healthcare insurance systems, etc., comparative studies among different 
subgroups like local communities and races in a country or across different time 
periods in a country might be very useful to find robust predictors that affect the 
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level of health outcomes after taking into consideration many confounding 
factors which is not possible or is difficult in a cross country level study.  
 For example, in the U.S, many previous studies have shown that the life 
expectancy gap between the highest and lowest local counties is about 18.4 years 
for men and 14.3 years for women, with even larger disparities for race-county 
combinations; smoking and high blood pressure can explain some of the life 
expectancy disparities among different races and counties in the U.S. (Daniel et 
al., 2010).  In the case of Australia, the increase of the smoking population 
resulted in large increases of mortality rates from lung cancer, heart disease, and 
respiratory diseases.  In fact, these increases of the mortality rate affected life 
expectancy negatively, especially in the 1960s. (Australian Institute of Health and 
Welfare, 2012)  
Even in cancer care, a lot of recent research studies have pointed out that 
health-related factors including cancer prevention, early detection, and 
coordination of suitable and timely cancer care, are very important to improve 
the efficiency of cancer treatment. (IARC, 2008; Yip et al., 2012; Sharma et al., 
2011)  In Korea, cases of unnecessary use of high priced screens, treatments, and 
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services have also been reported recently and this might result in the lower value 
of health services.  
Moreover, the WHO has recently developed a conceptual framework of the 
social determinants of health, and according to the framework, health outcomes 
can be influenced and differentiated by many socio-economic and political 
contextual factors. (Figure 8)  Especially, the comprehensive intermediary 
determinants of health, including material circumstances like neighborhood, 
social environmental factors like stress, behavioral and biological factors like 
smoking, and the health system play an important role in shaping the different 
health outcomes and their regional variations. (WHO, 2010, p.36-41)  This 
framework will be very useful for highlighting the influences of the 
comprehensive intermediary health determinants which can affect more directly 
the variations of local health outcomes and the value of HS in Korea.   
 “America’s Health Rankings” which started in 1990 to provide the 
state-by-state analysis of United States’ health status and the factors that affect it, 
has provided a comprehensive framework of health determinants and health 
outcomes; health outcomes are understood as the result of our behaviors, the 
environment, policies and practices of our health care, governments, and other 
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prevention systems, and the clinical care we receive. As an important aspect of 
health outcomes, the authors have included premature death and in that sense 
they have used the sum of years of life lost due to death before age 75 which is 
the Centers for Disease Control and Prevention (CDC)’s Years of Potential Life 




Figure 8. The Conceptual Framework of Social Determinants of Health 
 







2.3. Studies on the Value of Healthcare Services 
Generally speaking, the definition of value in healthcare is considered as 
“the health outcomes achieved or gained per dollar spent.” (Porter, 2010)  
Usually measuring value means assessing healthcare outcomes and healthcare 
costs jointly at the same time. (KPMG, 2013) (Figure 9)    Many economists and 
agencies have made major efforts to understand the concept of efficiency6 in 
economics under “the value equation (or quality/cost)” in the healthcare area 
since the achievement of greater efficiency under the given scarce resources 
would be a high priority in healthcare services as well.  Cost-Effectiveness 
Studies are also recognized as one of these efforts and recently “person-centered 
outcomes” are becoming major directions to improve the definition of efficiency. 
(Burgess, 2012)  Many studies of the different levels of value or efficiency in 
different healthcare settings have been performed at the country, community and 
individual levels. 
Overall, many studies on the regional variations of health outcomes and 
                                                          
6
  Efficiency is defined as three dimensions – technical, productive, and allocative. The technical 
efficiency measures simply examine the relation between health outcomes and resource inputs.  The 
productive efficiency means “the maximization of health outcomes for a given cost,” or “the minimization 
of cost for a given outcome.” And so the productive efficiency refers to “the relative value for money of 
interventions with directly comparable outcomes.”  The allocative efficiency measures the allocation of 
resources to maximize the welfare of the community or region. (Palmer & Torgerson, 1999) 
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healthcare spending have highlighted that a large part of variations in health 
care expenditures and outcomes can be linked to the variations in health 
determinants including behavioral and biological factors, community 
environment, and medical practices and utilization, and these variations have 
been tackled to improve value and equity of healthcare services as well. 
In the U.S, although the methodologies of Cost-Effectiveness Analyses 
(CEA) on the individual medical interventions were developed in the mid 1990’s, 
due to their private sector led health insurance systems, CEA studies have 
provided only general guidelines on which interventions might generally be 
preferable (Muennig, 2008, p.11).  But many studies on the regional variations of 
Medicare spending have concluded that patients in high-cost areas often receive 
more expensive care which was not associated with more effective health care 
services and better health outcomes.  Specifically, the lower-cost areas were 
using more efficient healthcare like programs to prevent or control smoking, and 
more effective preventive and follow-up services.  Now these issues are 
requiring not only value studies on specific treatments, but also studies on what 
makes health care systems higher value and more broadly successful  (Wennberg 
et al, 2002; Weinstein, 2010).   
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A study on the value of medical spending in the U.S. from 1960 to 2000, 
concluded that the increased spending on medical services since 1960 has 
resulted in reasonable increases in life expectancy on average, but for the elderly 
they showed somewhat higher cost per year of life gained. (Cutler et al., 2006)  
Recently, McKinsey & Company also concluded that the United States could 
save 300 to 450 billion dollars among total health expenditures by improving the 
health care services based on better preventive and more customized care if the 
country more fully utilized health-related “big data” on health care services and 
medical development. (McKinsey & Co., 2013) 
Moreover, some studies have also addressed whether regional variations 
in health expenditures, whether or not they result in better health outcomes and 
satisfaction with care, can be explained by the more “inpatient-based” and 
“specialist-oriented” patterns of care which are observed in high-cost areas. 
(Fisher et al, 2003)   
According to a study result from the famous Dartmouth Atlas Project in 
2009, higher Medicare spending regions have more hospital beds, more 
physicians overall, and more specialists per capita, more hospitalizations, more 
time in the ICU, more physician visits, and more diagnostic tests, while high 
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spending didn’t lead to better access to health care or better quality of care.  They 
concluded that hospitals and physicians have been incentivized through 
expanding capacity and providing additional procedures by specialists, and 
patients with more physicians and treatments have higher possibilities of more 
medical errors and unnecessary procedures. (Fisher et al, 2009)   
All these study results have suggested that healthcare reform efforts to 
achieve higher value healthcare systems should be highlighted continuously.  
In the UK, with their National Health Service (NHS) system, they have 
also addressed the evaluation issue at the health care system level like 
interregional comparisons of health performance, as well as at the micro-
economic evaluation level like CEA of specific treatments.  Recently they have 
recognized that regional variations in healthcare outcomes and expenditures 
have happened widely although the individual cost-effectiveness of high priced 
treatments and pharmaceutical medicines have been tested by the NHS for a 
long time;, therefore more attention has been paid recently on the value of non-
pharmaceutical interventions and innovations in the local health care delivery 
system (Smith & Laudicella, 2011; Sculpher, 2011).   
Regarding the future health care strategy, the department of health in the 
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UK is recognizing that the analysis and comparisons of the variations among 
regions and hospitals might be well utilized to improve health outcomes by 
facilitating better health care practices at the local community level like earlier 
diagnosis and transforming inpatient care.   
Moreover, in their recent (2010) white paper – “Healthy Lives, Healthy 
People: Our strategy for public health in England,” they suggested a new public 
health strategy to address the wider determinants of health including mental 
health, tobacco control, obesity, sexual health, pandemic flu preparedness, health 
protection and emergency preparedness at the local community level in order to 
focus on more personalized and preventive services that are associated with the 
achievement of the best health outcomes. But still there might be many future 
issues that will need to be considered as part of the NHS Outcomes Framework 
and relevant data production. (Department of Health, 2011) 
In the health economics perspective, issues on the global burden of disease 
have been widely addressed.  Very recently, the global burden of disease (GBD) 
2010 study results for 291 diseases and injuries in 21 regions globally were 
released based on a disability-adjusted life-years (DALYs) methodology which 
was based on their first 1990 study.  They calculated the sum of years of life lost 
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(YLLs) based on the remaining life expectancy per death at each age which 
represented the sum of premature deaths, and calculated years lived with 
disabilities (YLDs) based on the mean duration of each non-fatal illness or 
impairment phase multiplied by disability weights for each health state.7  They 
estimated that 2,490 billion years of healthy life were lost globally in 2010, and 
this was slightly up from the 1990’s result (2,503 billion).  They interpreted that 
GBD has continued to shift away from communicable to non-communicable 
diseases. (Murray at al, 2012).  But in the case of the DALY study, people with 
different nationalities and cultures might have different perceptions of 
disabilities and suffering.  Therefore the adaptation of disability weights has 
limitations in cross-country level comparisons. (Muennig, 2008, p.34)8  
Economic “costs” of diseases also were analyzed.  For example, in 2009 the 
global economic costs of cancer were analyzed based on new global cancer 
incidence and average treatment costs per case including medical costs, non-
                                                          
7
 Based on the DALYs methodology, a generalized CEA for national-level priority-setting in the health 
sector, namely WHO-CHOICE, was developed in 2003.  Here, the DALYs methodology has been used to 
compare the effects of different interventions for leading causes of certain diseases in the specific context 
of individual countries. (Hutubessy et al, 2003) 
 
8
 The global burden of cancer study results also vary by the research methodology. In the case of the 
Economist study based on “economic costs” of new cancer cases, they estimated US$305bn in 2009. In 
the global economic cost of cancer by the American Cancer Society and Livestrong in 2010 based on the 
economic impact of premature death and disability (DALYs) from cancer, they estimated US$895bn in 
2008. (Economist, 2009; American Cancer Society, 2010) 
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medical costs, and productivity losses. In this study, the cancer treatment 
expenditure gaps between countries were calculated based on the gaps between 
each country’s cancer case fatality rate and the global lowest cancer case fatality 
rate (Economist Intelligence Unit and Livestrong, 2009).  
According to the International Monetary Fund’s recent broad study on the 
efficiency of health expenditures, they pointed out that most previous cross-
country level studies measuring the efficiency of health spending did not control 
for the various socioeconomic factors that influence health outcomes.  In their 
new study, after controlling for some socioeconomic factors like educational 
achievement and urbanization, they found that African economies have the 
lowest efficiency and these economies could increase life expectancy up to nearly 
5 years by just improving the efficiency or value of health expenditures. (Grigoli 





Figure 9. Value Matrix: 4 quadrants 
 




2.4. Korea’s Studies on the Value of Healthcare Services 
In Korea, due to the somewhat short NHI history, the first CEA 
methodology was introduced to evaluate new pharmaceutical drugs for NHI 
reimbursement as an evidence-based decision making methodology in the 
Korean health care system in 2007.  Starting in 2008, the re-evaluations of already 
listed drugs in the NHI reimbursement list have been implemented, and in 
December 2011, the guidelines on CEA of pharmaceutical drugs were initiated 
by the HIRA.   
Recently, the new National Evidence-based Healthcare Collaborating 
Agency (NECA) has been set up since 2009 under the MOHW, and the scope of 
economic analysis on health care has been expanded gradually.  In 2010, the 
National Strategic Coordinating Center for Clinical Research (NSCR) was newly 
established under NECA by MOHW, and the Committee for New Health 
Technology Assessment (CNHTA) and the supporting center moved to NECA 
from HIRA at this point. (www.neca.re.kr) 
Related to the study on the economic analysis of the burden of disease in 
Korea, DALYs based on 2002 data were analyzed in 2007 and the study results 
showed that diabetes mellitus was the leading cause of the burden of disease 
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(970 DALYs per 100,000 population) followed by cerebrovascular disease (937 
DALYs) and asthma (709 DALYs) which were different from the leading causes 
of the burden of disease globally. In 2009, the study of DALYs of non-
communicable diseases (NCD) using 2007 data showed that cirrhosis of the liver 
in males and cerebrovascular disease in females became the biggest causes of the 
burden of disease in Korea. But further improvement of the DALYs methodology 
is needed, and future studies combining cost-effectiveness analysis with burden 
of disease studies have been proposed for better health resource allocation (Oh et 
al., 2011). 
 As a study of the economic costs of disease, the economic burden of 
cancer using 2005 data was analyzed in 2009 which was a major study on the 
burden of cancer in Korea. In this study, the burden was divided into direct costs 
and indirect costs.  Direct costs included medical and non-medical costs, and 
indirect costs included morbidity, mortality, and the caregiver’s time costs (Kim 
et al, 2009)  This study’s methodology was utilized in the global costs of cancer 
study by the Economist in 2009 as we discussed before.   
In 2011, the study on the impact evaluation of the change in medical 
services before and after the enhancement of NHI coverage of cancer treatment 
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was performed by the NECA since the NHI expanded the coverage of cancer 
patients including the reduction of patient out of pocket payment from 20% to 10% 
in 2005, and the reduction of patient out of pocket payment for inpatient and 
outpatient treatment from 10% to 5% in 2009.  In this study, the survival rate for 
one year increased gradually from 66.46% in 2006 to 83.06% in 2010 among the 
patients who received a lung cancer operation only, and from 44.61% to 51.47% 
among the patients who received lung cancer chemotherapy only.  (NECA, 2011) 
In the case of comparative studies of regional health care services, the 
regional disparities of health care services among local provinces have been 
focused on since the NHIC started producing their regional health services 
statistics for 2006 in 2008.  In 2010, related to the regional cancer care services, the 
disparities of cancer care resources between Seoul metropolitan areas and other 
areas, and somewhat big differences of death rates between cancer patients 
treated in the Seoul metropolitan area and in other areas were highlighted 
(NHIC, 2010).  In 2012, the regional health care system approach to analyze the 
disparities in regional health care services was also recommended by the Korea 
Institute for Health and Social Affairs (KIHSA) for future health studies in Korea.  
This study suggested that the regional health care system approach based on 
WHO’s conceptual framework on the Social Determinants of Health can help 
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define in the future the various regional determinants that generate differences 




2.5. Conclusions and Implications 
Under the framework of the social determinants of health, studies on the 
value of HS at the local community level might be very useful rather than the 
traditional CEA on a single health technology or medicine.  Since the traditional 
CEA of a treatment focuses on the improvement of individual health utilities in 
the standardized clinical setting without considering various determinants of 
health outcomes, it is somewhat difficult to capture the real influences of various 
health determinants which are affecting health outcomes in the real world setting.   
For example, the value of A treatment for patients in the B community and 
patients in the C community could be different in the real world setting due to 
the different levels of health determinants in each community.  The value of HS 
approach at the local community level in this study would be more useful to 
address these health determinants in the real world setting, and can highlight the 
relationships between the value of HS and the health determinants. 
In this regard, this study is important to define some health related factors 
in terms of the social determinants of health including health circumstances, 
behaviors and health systems which might be positively and strongly influencing 
lower premature death and better outcomes or higher values for healthcare in 
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the local community.  This can help health policy makers in Korea to design 
better health care policies that take into consideration the various health 
determinants related to lower premature death under the given NHI system. It 
can also help improve “the value for money” within the given health care 
expenditure level, considering the future fiscal constraints and aging population 









Chapter 3: METHODS 
 
3.1. Research Questions and Hypotheses 
Basically it is assumed that the recent National Health Insurance Health 
Expenditures (NHI HE) increase focusing on 4 severe disease categories in Korea 
might have contributed to lowering premature death which could be beneficial 
to help address the problem of a fast aging population in Korea.  But it is not 
certain that the contributions have had widely reasonable value at the local 
community level and how much variation among communities has been 
produced.   
In this context, the first research question in this study is “whether the NHI 
HE increases in Korea are associated with lowering premature death, and which 
local communities in Korea had the highest or poorest value of healthcare 
services in terms of premature death health outcomes?”  The value of HS might 
vary by local communities although their health insurance policies of NHI and 
prices of individual healthcare services under NHI are the same in all 231 local 
communities in Korea.  Even though the levels of NHI health care coverage and 
out-of-pocket costs are the same, the utilization of health care practices in the 
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actual health care settings might be different, and the various regional health 
circumstances and health behaviors can also affect the health outcomes in the 
local communities.   
Secondly, these variations in the value of HS at the local community level 
can be examined based on the different determinants of health in the local 
communities.  In this regard, the second research question is “which 
determinants of health in terms of health circumstances, health behaviors and 
health systems might positively or negatively be related to higher value of HS 
and better health outcomes at the local community level?”  Here it is assumed 
that well-managed health risk factors and efficient health resource utilization in 
the local communities will positively increase the NHI HE’s effect on premature 
death which means higher value of local HS and better health outcomes-- which 
is lower premature death- under the given NHI HE and health system.  For 
example, a relatively lower smoking rate, lower obesity rate, and lower stress 
rate in a certain local community can be positively related to a higher value of HS 
in that community.  Also efficient health utilization in terms of beds, physicians, 
and inpatient admissions and stays in a certain community can result in lower 
expenses of HS than in the communities with relatively excessive health 
utilization.   
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From this second question, this study will determine which health related 
factors and determinants can improve the value of HS and health outcomes in 




Table 3-1.  Main Study Hypothesis 
 Hypothesis 
1) The Effects of 
NHI HE on 
Premature Death 
- The recent NHI HE increase focusing on 4 severe 
disease categories in Korea might have effectively 
contributed to lowering premature death, but the 
Value of HS would vary among regions 
- In the case of certain regions like Seoul Metropolitan 
Area, the Value of HS might be different from other 
regions (Non-Seoul Metropolitan Area) 
2) The Modification 
of NHI HE effects 
on Premature 
Death by Local 
Health 
Determinants 
- Well managed Health Risk Factors at the local 
community level might be positively related to 
lowering Premature Death or the Value of HS - NHI 
HE effects on Premature Death 
- Relatively higher health utilization in terms of 
physicians, inpatient stays, and high-priced medical 
equipment might be negatively related to the Value of 





3. 2. Conceptual framework 
 As a first step, this study will construct two conceptual frameworks to help 
analyze the relationships between the Value of HS and health determinants in 
the local communities. 
First, a conceptual framework on how to measure local health outcomes in 
terms of premature death and the value of HS at the local community level (meso 
level) can be designed by using the concept of measuring value which is 
integrating the cost data and the health outcome data at the local community 
level.  This local health outcome framework can be different from the country 
level comparison model which is used to compare the cost or the burden of 
disease at the cross-country level (macro level model), and the individual 
intervention level CEA model which is used to analyze the CE of new treatments 
or medicines in the clinical or experimental setting (micro level model). 
Second, the local determinants of health outcome framework can be 
constructed based on the WHO’s conceptual framework of the social 
determinants of health (SDH) reviewed in the previous chapter.  Considering the 
study needs for a comprehensive analysis between health outcomes and various 
health determinants in Korea, this study framework will focus on the influences 
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of intermediary determinants in the SDH framework.9  Based on this simplified 
SDH framework, I will highlight the fact that better health circumstances, better 
health behaviors with better preventive care, and better health utilization and 
resource allocation in the local community are very important and influential in 
the real health care settings to improve the value of HS and so to ensure value for 
money and greater efficiency in the local health care system. 
 
3-2-1) Local Health Outcomes and Value of HS (Meso level approach)   
To measure the health outcomes at the local community level in terms of 
Value of HS, various conceptual frameworks on regional health outcomes can be 
defined.  According to the America’s Health Ranking framework reviewed in 
Chapter 2, the health outcomes represent the result of what has already occurred 
in terms of people’s health in the communities and the regions, and they 
categorized 10 indicators as components of health outcomes in their framework.  
First, as core components of health outcomes, they used 8 indicators – 
                                                          
9
 The WHO’s SDH framework includes a broader range of SDH including Structural Determinants like 
political context and socioeconomic position, and these structural determinants can influence the 
intermediary determinants of health. The relationship between the structural determinants and the 
intermediary determinants of health (IDH) will not be covered here, and can be performed by building on 
this study’s results on IDH in the future.  
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Diabetes, Poor Mental Health Days, Poor Physical Health Days, Geographic 
Disparity, Infant Mortality, Premature Death, Cancer Deaths, and Cardiovascular 
Deaths.  Second, as supplemental components of health outcomes, they used 2 
indicators – Health Status and Suicide10.   
After considering which of these indicators are most related to the local 
health outcomes in Korea, this study will focus on “premature deaths” as the 
core component of “the overall health outcomes in the local communities”11, 
since this variable can capture the total burden of premature deaths in each 
community as the number of years of life lost and controlling premature deaths 
should be one of the most important health policy agendas under the current fast 
aging population in Korea as we discussed previously.  This indicator can also 
well represent the overall community health performance in economic terms and 
can be defined as the sum of years of life lost.  
As another core component of the health outcomes for “specific disease 
categories”, I want to focus on “deaths due to cancers and suicide” considering 
that these causes of death have recently been recognized as major and important 








causes of death in Korea.  Also these two specific causes of death can represent 
well the performance of various and important forms of healthcare services at 
the local community level like inpatient care and mental healthcare services. 
Moreover, since higher cost sharing for the same health outcomes is not 
desirable in terms of efficiency considering the economic perspective and fiscal 
constraints, here we can define the local health outcomes together with the 
concept of costs invested for the population’s health at the community level.  In 
this context, we can use the value of HS concept to evaluate the local healthcare 
services under NHI system.  As an example, in a CEA, analysts compare the 
incremental cost per QALY gained (Quality Adjusted Life Years) between 
different medical interventions (Muennig, p.12-14).  But in the case of the overall 
health outcomes at the local community level, we need a broader value concept 
for the health of the entire population in the communities which will address the 
public health policy needs in the specific Korean context. 
 
3-2-2-1) Value of HS for the Overall Community Health 
To measure overall health outcomes of the population at the local 
community level in Korea, the overall premature death of the community 
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population can be the primary indicator.  According to the America’s Health 
ranking framework, “premature death measures the sum of years of life lost due 
to death before age 75 as defined by the CDC’s Years of Potential Life Lost 
(YPLL-75) framework, and it can be expressed by the sum of years of potential 
life lost (YPLLs) per 100,000 standardized population”12.  This methodology can 
be used in this study as well.  In terms of the value of the HS concept, this 
premature death measure can be combined with the total health care 
expenditures paid for the overall healthcare services in the local communities 
during the same period. 
First, based on the YPLL-75 methodology, the sums of years of potential 
life lost (YPLLs) in 231 local communities due to all causes of death can be 
calculated in 2007 and in 2012.  The incremental differences between 2007 and 
2012 in the 231 communities’ YPLLs can be the denominator in this value 
equation.  In the case of YPLLs, lower values would mean a better health 
outcome since higher YPLLs mean more and earlier deaths in the selected 
community.  And so the denominator will be calculated as the change in the 
averted YPLLs from 2007 to 2012 which are the YPLLs in 2007 subtracting the 
                                                          
12
 http://www.americashealthrankings.org/About/Definition#Premature Death 
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YPLLs in 2012.  This difference can be interpreted as the degree of improvement 
(or lack thereof) in YPLLs from 2007 to 2012, where improvement is defined as 
lower YPLLs in 2012 than in 2007. 
Second, the incremental total health expenditures per 100,000 population 
between 2007 and 2012 for each of the 231 communities can be calculated by 
using the NHI’s total healthcare expenditure data for each community and using 
this to construct the numerator in this value equation.  In this equation, since the 
value is measured by the amount of expenditure per year of lost life averted, a 
smaller number will be higher value in terms of shortening YPLLs as well as 
saving NHI health expenditures. 
 
 Value of Overall HS   
:  (Total Health Exp 2012– Total Health Exp 2007) / (YPLLs 2007 – YPLLs 2012)  
 
3-2-2-2) Value of HS for Cancer and Suicide 
Considering differences of disease prevalence by local communities, the 
value of local HS for a specific disease would also be very useful in addition to 
the value of the overall HS.  In this context, among the major 10 causes of death 
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in Korea, cancer and suicide are appropriate to utilize for this objective.   
Using the approach similar to the overall community health outcome, 
YPLLs and related Health Expenditures per 100,000 population for each cause of 
death – Cancer and Suicide in 231 communities, can be calculated and used in 
value equations for each cause-specific health outcome. 
 
 Value of Cancer Care Services   
:  (Health Exp on Cancer Care 2012 – Health Exp on Cancer Care 2007) /  
(YPLLs due to Cancer 2007 – YPLLs due to Cancer 2012)      
 
 Value of Mental Health Care Services   
:  (Health Exp on Mental Health Care 2012 – Health Exp on Mental 
Health Care 2007) / (YPLLs due to Suicide 2007 – YPLLs due to Suicide 
2012)     
 
3-2-2) Simplified Local Determinants of Health 
 Although the Korean NHI provides the same insurance policy for health 
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care services to all patients in all local communities and patients in every region 
can get the same benefits for medical treatments and medicines under the NHI 
system in Korea, the outcomes of health care services might be different among 
the 231 local communities due to the various local determinants of health 
outcomes displayed in Figure 9.  Since the type and level of the determinants 
including health circumstances, health behaviors, and health system 
characteristics like preventive care and efficiency of health services among 
communities might be different in Korea, the health outcomes and the values of 
HS in the local communities might be different as well.  Here we can suppose 
that the various determinants of health can affect the health outcomes of the 
population at the local community level. 
Based on this Local Determinants of Health (LDH) framework, the 
possible causal relationships in the local communities in Korea can be analyzed.  
From this comprehensive analysis of the various determinants of health and their 
influences on the local health outcomes and HS values, the direction for the 
optimization of local health circumstances, individual health behaviors, and 
health systems for higher value of local health care services in the policy 
perspective can be analyzed and formulated. 
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3.3. Study Design and Sources of Data 
This is a retrospective study, and the study population will be all 231 local 
communities (n = 231) in South Korea.  The 231 local communities will be 
regarded as the analysis and measurement units in this study, and I will mainly 
analyze how much values are produced by the local NHI healthcare services 
taking into consideration the given local determinants of health in the 
communities. 
To analyze and compare the variations of local premature death, this study 
will focus on comparing the value of NHI HS in the 231 local communities based 
on the local health outcomes and value of HS framework, and analyzing the 
factors that affect the variations of values in South Korea.  In this regard, this 
study will analyze the possible relationships in terms of value between 
premature deaths and NHI HE at the local community level, and possible local 
determinants of health that might affect the variations of the premature deaths 
and the value of HS among 231 local communities (n=231).   
In the results, this analysis will determine which factors might influence 
fewer premature deaths or a higher value of NHI HS at the local community 
level in Korea.  This might provide some important factors which can be used to 
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design more effective and efficient health policy in terms of healthcare 
expenditures and modifiable health determinants at the local community level. 
As we see in the Table 3-2, the health expenditures have increased steeply 
from 2009 due to the coverage expansion focusing on 4 severe disease categories, 
and related to those treatments, inpatient days and expenditures have increased 
very steeply as well.  According to a recent study done by NHIC in 2012, 11.6 
trillion KRW was funded for newly expanded coverage from 2005 to 2010, and 
25.8% of this was used for the coverage expansion of cancer treatment (Lee at al., 
2012).  Also according to the recent NHIC annual survey on the NHI coverage 
rate of total treatment costs, the average coverage rate for all treatments is 63.0%, 
while the average coverage rate for 4 severe disease treatments is 76.1% (NHIC, 
2013). 
To evaluate the recent NHI coverage expansion policy focusing on 4 
severe disease categories in terms of health outcomes and value of NHI HS, it 
might be very meaningful to study the health outcomes related to the steep 
increase of health expenditures in 2009 and 2010.  And therefore, I will set up the 
study period for 5 years from 2007 to 2012, and focus on the changes in the main 
variables between 2007 and 2012.   
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Considering the very recent debate on higher coverage expansion for 4 
severe diseases among Korean politicians, this study period might also be 
helpful in assessing how the recent NHI coverage expansion policy focusing on 4 
severe disease categories has produced higher value of HS in the perspective of 
public health policy as we discussed previously. 
In order to calculate the value of cancer care services, we considered 
incidence rates by cancer site, total NHI payments, treated patients, mortality 
rates, and annual payment growth rates in Korea.  The decision made was to 
focus on five major cancers including stomach cancer, liver cancer, lung cancer, 
colorectal cancer, and breast cancer.  (See Tables 3-3 and 3-4) 
All local health care data and statistics were collected from the official 
health data sources in Korea which included the Korea National Statistics Office 
(NSO or KoStat), Ministry of Health and Welfare (MOHW), NHIC, National 











2007 2008 2009 2010 2011
Nominal GDP (trillion won) 975 1,026 1,065 1,173 1,247
*Annual growth (real) 2.3 0.3 6.3 3.7
Population (1,000 persons) 47,820 48,160 48,614 48,907 49,299
Mortality Rate (per 100,000 standardized) 459 439 421 414 398
Mortality Rate by Cancer 127 124 120 119 113
Mortality Rate by Suicide 23.9 24.7 29.1 28.7 28.8
Infant Mortality Rate (per 1,000 persons) 3.8 3.5 3.3 3.5 3.2
Total Fertiliy Rate (persons) 1.25 1.19 1.15 1.23 1.24
Health Expenditure 323,892    348,690    393,390    436,283    462,379    
*Annual growth 7.66 12.82 10.9 5.98
Inpatient Expenditure 98,613      108,924    123,880    144,388    154,365    
*Annual growth 10.46 13.73 16.56 6.91
Total Inpatient Days 74,980      83,920      92,626      103,638    108,487    
*Annual growth 11.92 10.37 11.89 4.68
Over 65 Health Expenditure 91,190 107,371 124,236 141,350 153,768
*Annual growth 17.74% 15.71% 13.78% 8.79%
Health Exp per Capita (KRW) 677,319 724,027 809,218 892,071 937,904
*Annual growth 6.90% 11.77% 10.24% 5.14%
Over 65 Health Exp per Capita (KRW) 2,078,608 2,334,373 2,574,079 2,839,059 2,965,989
*Annual growth 12.30% 10.27% 10.29% 4.47%
Health Exp for Neoplasm(C00-D48) 26,255 33,624 37,703 42,409 46,007
*Annual growth 28.07% 12.13% 12.48% 8.48%
Health Exp for Mental Disease(F00-F99) 9,885 13,095 14,996 17,482 19,711
*Annual growth 32.47% 14.52% 16.58% 12.75%
CPI 2.5 4.7 2.8 3.0 4.0
NHI Treatment Price Increase 2.3 1.94 2.2 2.05 1.64
NHI premium Increase 6.5 6.4 0 4.9 5.9
NHI Annual Profit/Loss -2,847 13,667 -32 -12,994 6,008
NHI Benefit Policy Rate 64.4 62.0 63.6 62.7 63.0
(Scale: 100,000,000 KRW, %) (Source: NSO and NHIC Database)
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2009 133,065 2,179,493 11,685,450 423,374,515 380,923,485 
2010 143,505 2,302,637 12,504,687 452,428,854 423,956,873 
Liver(C22) 
2009 54,334 1,434,200 9,462,484 364,333,664 328,185,849 
2010 58,417 1,517,775 10,734,921 409,253,669 384,329,780 
Lung 
(C33-C34) 
2009 54,558 1,694,953 7,100,347 407,033,409 365,921,875 
2010 59,011 1,862,203 7,952,676 459,786,820 431,144,959 
Colorectal 
(C18-C20) 
2009 103,679 2,202,427 9,140,397 477,861,186 430,517,250 
2010 113,604 2,409,379 9,895,856 524,226,070 492,362,109 
Breast(C50) 
2009 93,811 1,805,878 17,958,259 335,677,170 303,120,722 
2010 103,541 2,035,592 20,379,829 403,919,880 379,659,486 
Cervix(C53) 
2009 29,920 438,612 2,643,327 72,224,286 65,293,964 
2010 30,586 460,172 2,847,821 78,210,326 73,420,428 
 
 
Table 3-4. Major Cancer Sites and Mortality Rates in Korea (2010) 




No. of Death 
(2010)  
Proportion (%)  
Mortality Rate 
(per 100,000 persons)  
Total C00-C97  72,046  100.0  144.  
Lung C33-C34  15,623  21.7  31.3  
Liver C22  11,205  15.6  22.5  
Stomach C16  10,032  13.9  20.1  
Colorectal C18-C21  7,701  10.7  15.4  
Pancreas C25  4,306  6.0  8.6  





3.4. Variables and Measures 
A number of factors were considered in selecting and measuring all the 
specific variables for this study in order to increase its credibility and validity.  
Variable selection was guided by the study objectives to analyze values of HS 
and their variations by using the local health outcomes of premature death 
(dependent variables), NHI HEs (main independent variables), and the 
determinants of health (other independent variables and effect modifiers) based 
on the study framework.  The availability and feasibility of accessing data from 
the official data sources in the Korean government agencies was also considered. 
 
3-4-1) Dependent Variables (Health Outcomes) 
First, to calculate and analyze the value of HS within the overall local health 
outcome framework, all averted premature deaths (averted YPLLs) before age 75 
in 231 local communities between 2007 and 2012 are used as the main dependent 
variables.  The mortality rate data for all age stratifications from 0 to 75 in 231 
communities were obtained from the Korea Statistics Agency (KoSTAT) database, 
and the YPLLs in 231 communities were calculated by using these mortality rate 
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data for the 231 communities, average Years of Potential Life Lost before age 75 
in all age stratifications, and the standardized population in all age stratifications, 
using 100,000 standardized population in each community.  The final YPLL 
variable was calculated as the total sum of years of potential life lost in all age 
stratifications per 100,000 standardized population in each community.  
Second, with regard to the local health outcome variables of cancers and 
suicides in the 231 communities, the averted YPLLs by 5 major cancers in Korea 
including stomach, lung, liver, colorectal, and breast cancers, and suicides 
between 2007 and 2012 were used as the main secondary dependent variables for 
specific disease health outcomes in this study.  
All of these dependent variables for overall and specific disease health 
outcomes were compared among the 231 local communities and the variations 
among the local communities were also analyzed. 
 
3-4-2) Independent Variables 
To calculate values of overall HS and specific disease HS based on the local 
value of HS framework, the change of NHI HE per 100,000 population in each 
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community between 2007 and 2012 was divided by the incremental change of 
YPLLs between 2007 and 2012 in the community.  Since we consider the averted 
YPLLs between 2007 and 2012 as the dependent variables, the incremental 
changes of NHI HEs per 100,000 population in the local communities are the 
main independent variables and their coefficients can represent the values of 
HS13 in the linear regression analysis. 
 
3-4-3) Potential Predictors and Effect Modifiers (Local Determinants of Health) 
Assuming that potential health related predictors (health determinants) can 
not only influence the averted YPLLs (dependent variable) but also modify the 
influences of incremental NHI HEs (independent variable) on the averted 
YPLLs14 in the linear regression model, the health determinants can be defined as 
effect modifiers of the NHI HEs. 
Based on the Local Determinants of Health framework, various health-
related predictors including material circumstances, health behaviors, and health 
                                                          
13
 In this case, the values (ΔNHI HEs/ΔYPLLs) will be 1/(coefficients of NHI HEs). 
14
In this case, the values can be bigger or smaller by effect modifiers. 
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system characteristics can be defined.  To test potential relationships between the 
values of HS and health determinants at the local community level, many 
indicators related to health environments, health risk factors, and health 
utilization in the 231 communities have been collected and included from the 
official data sources. 
First, for the material circumstance component, “Rate of Apartment 
Homes”, “Average Community Income”, and “Rate of Health and Welfare 
Budget” are considered.  For the indicator of average community income, the 
average NHI premiums by local communities are used since the individual NHI 
premiums are mainly decided by individual monthly income.   
Second, as variables for the behavioral and biological factors, “rate of 
smoking in the population”, “obesity rate”, “rate of hypertension in the 
population”, and “diabetes rate in the population” in each local community have 
been included.    
Third, for the psychosocial circumstances, “stress rate” and “depression rate” 
are chosen.  
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Lastly, for the health systems factors, “check-up rate”, “the number of 
physicians & beds per person”, “average length of stays (LOS) and average 
hospital visit days per person”, “number of high priced health care equipment 
(CT & MRI)” in each local community have been included as well.  These 
variables measuring various dimensions of health systems might represent the 
level of health risk factor management and preventive care, health utilization, 
and health resource allocation in the local communities.  
All of these 16 effect modifiers for 231 communities were collected from 
MOHW and NHIC databases for the analysis, and the level of the variables in 
certain years or the incremental changes between 2007 and 2012 were included in 
the analysis.  In the case of all behavioral and psychosocial variables, both the 
levels of 2007 and 2012, and the incremental changes from 2007 to 2012 are 
analyzed.  Here I suppose that some variables didn’t change a lot annually since 
some variables have the characteristics of “Stock” level data, and therefore they 
might have threshold effects and the level of certain years might be more 





3-4-4) Control variables 
Age and gender can be considered as possible confounding factors.  To 
consider the differences of age and gender distributions among local 
communities, the rate of people over age 65 and the rate of women among the 
total population in each local community have been added to the independent 
variables to control for and adjust for their influences.  But since we use 100,000 
standardized population in each community to calculate the dependent variable 





Table 3-5. Dependent Variables 





of All Premature 
Deaths (Y1) 
The averted sum of years of potential life lost 
(YPLL) per 100,000 persons (average standard 
population) due to all deaths in the community 









Death due to 5 
Major Cancers 
(Y2)  
The averted sum of years of potential life lost 
(YPLL) per 100,000 persons due to 5 major 
Cancers(Stomach, River, Lung, Colorectal, 
Breast) in the community between 2007 and 




Death due to 
Suicide (Y3)  
The averted sum of years of potential life lost 
(YPLL) per 100,000 persons due to Suicide in 







Table 3-6. Main Independent Variables (NHI HEs) 





HE for overall 
health care 
Incremental Total NHI Health Expenditures for 
overall health care services per 100,000 
persons in the community between 2007 and 







HE for 5 Major 
Cancer care 
Incremental Total NHI Health Expenditures for 
5 Major Cancers (Stomach, Liver, Lung, 
Colorectal, Breast) care services per 100,000 
persons in the community between 2007 and 
2012 (1 million KRW) 
Continuous 
Incremental NHI 
HE for Mental 
Health care 
Incremental Total NHI Health Expenditures for 
Mental Health care services per 100,000 
persons in the community between 2007 and 








Table 3-7. Other Independent Variables (Effect Modifiers) and Control Variables 




Rate of  
Apartment 
Homes 
Percentage of Apartment Homes among All 







Average annual NHI premium in the local 




Rate of  Health 
& Welfare 
Budget 
Percentage of Local government Health and 
Welfare budget among total Local 
Government Budget (%) 







Smoking Rate Percentage of Persons who smoked more than 
100 cigarettes and are smoking now(%) 
*(MOHW Community Health Survey) 
Continu
ous 
Obesity Rate Percentage of Persons who are over 25 points 
in BMI (%) 





Percentage of Hypertension Patients (%) 
*(MOHW Community Health Survey)) 
Continu
ous 
Diabetes Rate Percentage of Diabetes Patients (%) 






Stress Rate Percentage of High Stressed persons (%) 
*(MOHW Community Health Survey) 
Continu
ous 
Depression Rate Percentage of persons who experienced the 
depression (%) 





































Number of High 
Priced Health 
care Equipment 
Number of high priced health care equipment 




Check-up Rate Percentage of Persons who did more than one 







Percentage of Persons who were consulted 
normal condition among Persons who did 






Over 65 people 
Rate 













Table 3-8. Results of Data Collection (Univariate Analysis) 
Categories/ 
Determinants 
Variables Range of Data (n = 231) 






for  All Premature 
Deaths  








for  Premature 
Death due to 5 
Major Cancers 
(Y2)  
-1087 60 187 283 958 176 
(243) 
Averted YPLLs 
for  Premature 
Death due to 
Suicide (Y3)  







HE for overall 
health care  
-30195 31796 43931 62524 281492 48698 
(27388) 






HE for 5 Major 
Cancer care (X2) 




6.0 7.4 7.7 7.9 9.6 7.6 
(0.46) 
Incremental NHI 
HE for Mental  
Health care (X3) 









Health care (X3) 















Income (NHI fee) 
170 344 430 627 11717 634 
(915) 




Rate of Health & 
Welfare Budget 
4.6 15.5 22.6 35.0 58.9 26.4 
(13.1) 





Smoking Rate -10.1 -1 1 3 8.8 0.9(3.1) 
Obesity Rate -11.2 -4.7 -2.5 -0.2 17.7 -2.5(3.4) 
Hypertension 
Rate 
-10.4 -3.8 -2.2 -0.5 4.3 -2.2(2.3) 
Diabetes Rate -5.4 -1.9 -1 -0.2 3.8 -1.1(1.5) 
Psychosocial 
circumstances 
Stress Rate -20.1 -3.8 0.2 3.7 21.4 0.06(6.3) 
Depression Rate -9.4 0.7 2.8 5.2 12.9 2.9(3.5) 
Health 
systems 
Physicians 0.7 1.5 1.8 2.3 20.6 2.3(2.1) 
*Log(Physician) -.36 0.41 0.59 0.83 3.03 0.67 
(0.47) 
Hospital Beds 0.3 7.2 11.0 15.9 43.9 12.4(7.3) 




5.6 6.6 7.0 7.5 9.5 7.1(0.7) 




17.2 20.1 22.7 27.3 36.4 23.9(4.6) 
*log(Visit Days) 2.8 3.0 3.1 3.3 3.6 3.2 
(0.18) 
Number of High 
Priced Health care 
Equipment 
0 2 7 18 102 12.1(14.0) 
*Log(Equipment) 0 1.1 2.1 2.9 4.6 2.0 
(1.16) 
Check-up Rate 62.4 69.9 72.4 74.5 81.7 72.2(3.5) 
*Normal Result 
of Check-up Rate 
35.1 43.0 47.0 50.2 58.9 46.6(4.8) 
* Control 
Variables 
Over 65 people 
Rate 
5.2 10.0 13.7 22.2 32.6 16.2(7.4) 





3.5. Statistical Analysis Plan 
 
3-5-1) Value Analysis and Simple Linear Regression 
First, the Values of HS defined as the influences of NHI HEs increases on 
the averted premature deaths between 2007 and 2012 regarding the three 
healthcare services – Overall, Cancer care, and Mental Care, were analyzed in 
231 local communities based on the local value of HS framework as we’ve 
discussed in Chapter 3.  
Also, to compare associations and variations regarding the influence of 
NHI HE increases on the averted premature deaths (YPLLs-75) between 2007 
and 2012 based on the value analysis in the three health services – Overall, 
Cancer Care, and Mental Care, simple linear regression models (n=231 local 
communities) were constructed separately for the three health services categories, 
assuming that the relationship between NHI HEs and YPLLs-75 is linear and 
subject to random error.   
The results of value analyses in terms of the value gained per dollar spent 
were compared with the result of the simple linear regression models as well. 
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In the regression equation (1) below, β1 represents the averted years of life 
lost per increased healthcare expenditure and bigger β1 means higher value of 
NHI NE between 2007 and 2012.   
Specifically, based on the local determinants of health framework as we’ve 
discussed previously, to analyze the influences of various determinants on health 
outcomes at the local community level, the simple linear regression model 
should be expanded to the multivariate linear regression model. 
 
(1)  averted YPLL-75i   
=  α +  𝛽1𝑁𝐻𝐼 𝐻𝐸i +  𝜀𝑖  
 
3-5-2) Multivariate Linear Regression and Effect Modification of Local 
Determinants of Health 
Second, to analyze the modifying effect of local determinants of health 
(LDH) in 231 communities on the value of HS as well as the influences of various 
determinants on health outcomes at the local community level, Multiple Linear 
Regression (MLR) models (n = 231 local communities) were constructed with the 
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various independent variables of the local determinants and the interaction 
terms.   
 
(2) averted YPLL-75i  =  α +  𝛽1𝑁𝐻𝐼 𝐻𝐸i + 𝑁𝐻𝐼 𝐻𝐸i
∗ ( 𝛽2Housingi + 𝛽3𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝐶𝑜𝑚𝑚𝑢𝑛𝑖𝑡𝑦 𝐼𝑛𝑐𝑜𝑚𝑒i
+ 𝛽4𝑆𝑚𝑜𝑘𝑖𝑛𝑔i + 𝛽5𝑂𝑏𝑒𝑠𝑖𝑡𝑦i +  𝛽6𝐻𝑦𝑝𝑒𝑟𝑡𝑒𝑛𝑠𝑖𝑜𝑛i
+ 𝛽7𝐷𝑖𝑎𝑏𝑒𝑡𝑒𝑠i +  𝛽8𝑆𝑡𝑟𝑒𝑠𝑠i +  ∙  ∙  ∙)
+  ( 𝛽17Housingi + 𝛽18𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝐶𝑜𝑚𝑚𝑢𝑛𝑖𝑡𝑦 𝐼𝑛𝑐𝑜𝑚𝑒i
+ 𝛽19𝑆𝑚𝑜𝑘𝑖𝑛𝑔i + 𝛽20𝑂𝑏𝑒𝑠𝑖𝑡𝑦i +  𝛽21𝐻𝑦𝑝𝑒𝑟𝑡𝑒𝑛𝑠𝑖𝑜𝑛i
+ 𝛽22𝐷𝑖𝑎𝑏𝑒𝑡𝑒𝑠i +  𝛽23𝑆𝑡𝑟𝑒𝑠𝑠i +  ∙  ∙  ∙) + 𝛽32𝑂𝑣𝑒𝑟 𝐴𝑔𝑒 65i
+  𝛽33𝐹𝑒𝑚𝑎𝑙𝑒i + (𝛽34𝑆𝑒𝑜𝑢𝑙 𝑀𝑒𝑡𝑟𝑜i) + (𝛽35𝐶𝑖𝑡𝑦i) +  𝜀𝑖 
 
In this MLR health outcome model, it is assumed that the collection of 16 
independent variables and effect modifiers exert an observable and significant 
influence on the values of HS in all 231 local communities.  By using bivariate 
analyses, all the independent variables (16 potential effect modifiers) were also 
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tested to select significant independent variables that might have some 
influences on the averted YPLLs-75 directly at the local community level.15 
Each independent variable and effect modifier was tested one by one 
during the process of exploratory analysis, and relevant variables whose 
modifying effects were somewhat bigger and significant were selected.  Multi-
collinearities and interactions among selected variables were also checked and 
the models were redefined through reorganization of selected independent 
variables and effect modifiers.  
More specifically, to analyze the characteristics of communities in certain 
regions, I also compared the differences between the Seoul metropolitan area (3 
provinces) and other areas (13 provinces) 16.  Here I suppose that although Korea 
is a small country, the characteristics of the Seoul metropolitan area might be 
somewhat different from other regions since there are somewhat big differences 
among regions in terms of health system characteristics, health utilization, and 
health risk management due to the different economic resources and capacities.  
                                                          
15
 In the bivariate analysis, if p-value of independent variable is less than 0.30, the variable will be 
selected to construct the final MLR model.  
 
16
 231 communities are located in and divided into 16 provinces in Korea.  Among 16 provinces, 3 
provinces including Seoul City, In-Cheon City, and Gyoung-Gi Province are called Seoul Metropolitan Area 
which is the most developed area in Korea.  
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To examine any association with city or rural region characteristics, the dummy 
variable on city area was added to the model as well. 
Moreover, normality, leverage, influence, and residuals were checked 
separately and the model was improved through a fitting process and deleting 
extreme outliers.  Both forward and backward selection methods were also used 
to select the final independent variables and effect modifiers to finalize the MLR 
health outcome models. 
Based on these statistical analyses, several different local health outcome 
models were defined and in each model, the value of HS and the effects 
modification of various local determinants of health (effect modifiers) on the 
values were determined and interpreted based on the statistical significance and 
coefficients of the independent variables and effect modifiers.   
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3. 6. Protection of Human Subjects 
Legally NHIC and other national health data sources in Korea don’t 
provide any individual identifiers and private health and medical information.  
But using the de-identified information is allowed by law and so all the 
information were collected under the form of blinded status which doesn’t have 
an enrollee’s real name and identification number.   
All information and data in this study were used for statistical analysis 
purposes only.  The School IRB approved that this analysis is not human subjects 
research because this thesis is based on secondary data collected by the official 
agencies in Korea, and there are no data that could identify human subjects 





Chapter 4: Results 
 
4. 1. Value of HS 
The Value of HS in terms of the influence of NHI HEs increases on 
premature deaths (the averted YPLLs-75) between 2007 and 2012 regarding 3 
health care services - overall health care, cancer care, and mental health care 
services, were calculated and compared in 231 local communities.  Here the 2007 
NHI health care services would be the baseline cases, and the 2012 NHI health 
care services would be the comparison cases. 
In the traditional cost-effectiveness analysis, if an intervention is less 
expensive and more effective (improved health outcomes), the intervention is 
certainly dominant (preferred) compared with the baseline case.  If the 
intervention is more expensive and less effective, it is dominated by the baseline 
case.  If the intervention is more expensive and more effective, it should be 
decided whether the government is willing to pay the further expense to 
improve health by using the intervention.  (Muennig, 2008, p.30) 
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Three scatter plots of the values of HS in terms of the association between 
expenditures and the averted YPLLs from 2007 to 2012 for the three healthcare 
services, were constructed.  Inflation adjusted expenditures based on 
the consumer price index (CPI) in Korea from 2008 to 2012, were used and I also 
discounted the YPLLs in 2012 with the annual discount rate as 3% which is usual 
in the economic analysis design. 
 In examining the scatter plots (Figure 11, 13, and 15), all the 
expenditures were increased from the 2007 level except for only 1 or 2 
communities which might be outliers.  In the case of outcomes (the averted 
YPLLs-75), the averted YPLLs associated with overall healthcare services in 2012 
were increased in 217 communities among 231 (93.9%), the averted YPLLs for 
cancer care services were increased in 214 communities (92.6%), and the averted 
YPLLs for mental care services were increased in only 132 communities (57.1%).   
If we observe the North-East quadrant of scatter plots, the values of HS 
(slope of each point from 0-0 point) are plus numbers, but different and various 
levels among communities.  Although there is no specific benchmark value or 
threshold level of value in the three health care services, it is difficult to divide 
strong values or weak values in the graphs.   
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But considering the distributions of values in the cumulative graphs (Figure 
12, 14, 16), it is possible to check how strong the values are for the local health 
services.  First, in the case of overall healthcare, most values are between $0 and 
$250,000 per 1 averted YPLL.  Second, in the case of cancer care, most values are 
between $0 and $40,000 per 1 averted YPLL.  Third, in the case of mental care, as 
over 40% of the communities are located in the North-West quadrant of the 
scatter plot which means worse outcomes and higher cost and dominated by the 
2007 cases, nearly half of the values of HS are getting worse since 2007, and in the 
case of positive values of mental care, they are between $0 and $300,000 per 1 
averted YPLL. 
Based on the bootstrapping analysis method (O’Brien & Briggs, 2002), 
bootstrapped values for the 3 health care services were also constructed with 
1000 repeated random samples17 for each health care service (Figure 17, 18, 19).  
First, in the scatter plot for overall healthcare (Figure 17), only 62 plots are in the 
North-West quadrant out of a total of 1000 plots.  These are undesirable 
                                                          
17
 These repeated random samples were calculated by using each Mean value and Standard Deviation 




outcomes18 (worse outcome and higher cost) since these cases are dominated by 
the baseline cases in 2007.  Among 938 plots, the confidence intervals of the 
bootstrapped values for overall healthcare services are from 3,787 (2.5%) to 
203,075 (97.5%).  
Secondly, in the scatter plots for cancer care (Figure 18), there are only 28 
plots in the North-West quadrant out of a total of 1000 plots. These represent 
undesirable outcomes (worse outcome and higher cost) since these cases are 
dominated by the baseline cases in 2007.  Among 972 plots, the confidence 
intervals of the bootstrapped values in cancer care services are from -78 (2.5%) to 
59,546 (97.5%).   
Finally, in the scatter plots for mental health care (Figure 19), the 328 plots 
in the North-West quadrant out of a total of 1000 plots represent worse outcomes 
and higher cost signifying that these cases are a worse alternative than the 
baseline cases in 2007.  In contrast to the overall and cancer care cases, 32.8% of 
the bootstrapped values are dominated by the baseline cases in 2007.  Therefore, 
                                                          
18
  Instead, the plots in the South-East quadrant show that their minus values are less expensive (the 
increased NHI expenditures are minus values) and more effective (the averted YPLLs are plus values).  
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it could not be concluded that the mental health services in 2012 might have 
higher value compared with the mental health services in 2007. 
With these results, in the case of overall health care and cancer care cases, it 
can be assessed that the NHI healthcare systems in 2012 might have produced 
higher values compared with the NHI systems in 2007 after NHI expenditure 
increases.  But in the case of mental health care, I cannot assess that the 2012 NHI 
health care system compared with the 2007 system has or has not produced 
higher value after NHI expenditure increases, since the range of values are so 
wide in the study results.  
In the next section, based on the value of HS models with the 2 variables 
here - the increased NHI expenditure and the averted YPLLs-75, simple linear 
regression models were tested to determine if higher increases of NHI 
expenditures are associated with greater decreases of YPLLs. 
In addition, I constructed and analyzed “multivariate linear regression 
models” with other health determinants as well as NHI expenditures to find 
which determinants of health can result in variation of values or better averted 
YPLLs and higher values in overall healthcare, cancer care, and mental health 
care at the local community level in Korea. 
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19
 In this scatterplot, the X axis represents the averted YPLLs (outcomes) between 2007 and 2012 per 
100,000 standardized population in the communities and the Y axis represents the increased NHI 









-6000 -4000 -2000 0 2000 4000 6000 8000
Values of Overall HS 
(NHI Expenditures to Averted YPLLs, 2007 to 2012) 
Better outcomes and more expensive— 
Ask whether the 2012 case has higher value relative to the 2007 case  
Worse outcomes and more expensive— 
Dominated by the 2007 case 
Better outcomes and less expensive— 
Dominates the 2007 case 
89 
 


















-750.00 -500.00 -250.00 0.00 250.00 500.00 750.00 1,000.00 1,250.00
Cumulative Distribution Graph 
90 
 












-1000 -500 0 500 1000
Values of Cancer Care Services 
(5 Cancer_Expenditures to 5 Cancer YPLLs, 2007 to 
2012) 
Better outcomes and more expensive— 
Ask whether the 2012 case has higher value relative than the 2007 case  
Worse outcomes and more expensive— 
Dominated by the 2007 case 
Better outcomes and less expensive— 
Dominates the 2007 case 
91 
 


















-200.00 -160.00 -120.00 -80.00 -40.00 0.00 40.00 80.00 120.00 160.00 200.00
Cumulative Distribution Graph 
92 
 

















-1500 -1000 -500 0 500 1000 1500 2000
Values of Mental Health Care Services 
(Mental Care Exp to Suicide YPLLs, 2007 to 2012) 
Better outcomes and more expensive— 
Ask whether the 2012 case has higher value relative to the 2007 case  
Worse outcomes and more expensive— 
Dominated by the 2007 case 
93 
 

















-1,200.00 -900.00 -600.00 -300.00 0.00 300.00 600.00 900.00 1,200.00
Cumulative Distribution Graph 
94 
 












-3000 -2000 -1000 0 1000 2000 3000 4000 5000 6000 7000
Better outcomes and less expensive— 
Dominates the 2007 case 
Worse outcomes and more expensive— 
Dominated by the 2007 case 
Better outcomes and more expensive— 
Ask whether the 2012 case has higher value relative to the 2007 case  
95 
 













-400 -200 0 200 400 600 800 1000
Better outcomes and less expensive— 
Dominates the 2007 case 
Worse outcomes and more expensive— 
Dominated by the 2007 case 
Better outcomes and more expensive— 
Ask whether the 2012 case has higher value relative to the 2007 case  
96 
 












-600 -400 -200 0 200 400 600 800
Better outcomes and less expensive— 
Dominates the 2007 case 
Worse outcomes and more expensive— 
Dominated by the 2007 case 
Better outcomes and more expensive— 
Ask whether the 2012 case has higher value relative to the 2007 case  
97 
 
4.2. Value of Overall Healthcare Services Model 
 
 4-2-1) Bivariate and Multivariate Analysis 
In the bivariate analyses (Table 4-1) examining associations between 
YPLLs and each of the 33 independent variables,  including the main 
independent variable (Overall Health Care Expenditure) and 2 control variables (% 
female, % over age 65) in 230 communities20, 18 independent variables were 
selected for the multivariate analyses since their P-values are higher than 0.300. 
(Table 4-2) 
From the exploratory analyses, including the multi-collinearity analysis, 
and the selection processes in the multivariate analyses, 8 independent variables 
were selected, including health expenditures, smoking rate in 2012, depression, 
number of physicians, number of beds, length of stay, number of high-priced 
equipment (CT & MRI), and check-up rate. (Table 4-3)   
 
                                                          
20
  Among the 231 communities, 1 community which is negative regarding the incremental 
expenditures for overall health care, was excluded from the analysis since the community would be an 
extreme outlier in the analysis (see Figure 10).  
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The Multivariate Analysis with 8 independent variables was also tested 






Table 4-1.  Results of Bivariate Analyses (n = 230) 
 Independent 
Variables 
Results (n = 230) 
Coefficient P-Value 
Mean Lowest Highest 
Expenditure 0.0195 0.0084 0.0306 0.001 
*log(exp) 762 335 1190 0.001 
Apartment -12.6 -20.4 -4.8 0.002 
Income -0.119 -0.335 0.097 0.280 
*log(NHI Fee) -292 -643 58 0.102 
Health Budget -16.9 -31.9 -1.94 0.027 
*log(Budget) -506 -909 -103 0.014 
Smoking -62.9 -126.1 0.406 0.051 
*Smoking_12 76 -4.0 156 0.062 
Obesity 19.5 -39.4 78.4 0.514 
*Obesity_12 -11.6 -83.0 59.9 0.750 
Hypertension -33.3 -118.6 52.1 0.443 
*Hyper_12 -71.8 -162.3 18.7 0.119 
Diabetes -38.6 -173.04 95.9 0.572 
*Diabetes_12 -45.9 -209 117 0.579 
Stress 15.5 -15.9 46.9 0.331 
*Stress_12 -39.5 -84 4.7 0.080 
Depression -32.5 -88.4 23.5 0.254 





Physicians -132.6 -227.5 -37.6 0.006 
*log(physician) -493 -905 -81 0.019 
Beds 7.1 -20.1 34.3 0.607 
*log(beds) 161.4 -135.9 458.7 0.286 
LOS -152.2 -424.3 119.96 0.272 
*log(LOS) -1142 -3108 824 0.253 
Visit Days 83.7 41.9 125.6 0.000 
*log(Visits) 2133 1084 3183 0.000 
CT/MRI -21.9 -35.7 -8.0 0.002 
*log(CTMRI) -422 -584 -259 0.000 
Check-up -42.9 -98.9 13.1 0.133 
*Check-up®  -45.7 -86.5 -4.9 0.028 
Over 65 43.1 17.0 69.2 0.001 
Female 29.5 -142.3 201 0.735 
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Table 4-2. Multivariate Analysis with 18 independent variables 
Independent 
Variables 
Results (n = 230)  *P-Value=0.001, R2=0.1901 
Coefficient P-Value 
Mean Lowest Highest 
*log(exp) 349 -985 1682 0.607 
Apartment 3.4 -19 26 0.763 
*log(NHI Fee) -114 -527 299 0.587 
*log(Budget) 318 -499 1137 0.443 
Smoking -3.7 -75 68 0.920 
*Smoking_12 46 -51 142 0.352 
*Hyper_12 -13 -124 98 0.820 
*Stress_12 1.7 -49 52 0.949 
Depression -40 -97 17 0.169 
*log(physician) -492 -1048 64 0.083 
*log(beds) 132 -381 645 0.613 
*log(LOS) -1843 -5885 2199 0.370 
*log(Visits) 594 -3345 4533 0.767 
CTMRI -12 -31 7.3 0.222 
Check-up -93 -169 -16 0.018 
*Check-up®  74 -3.9 152 0.062 
Over 65 28 -75 130 0.597 





Table 4-3. Multivariate Analysis with 8 independent variables  




Results (n = 230) *P-Value=0.000, R2=0.1479 
Coefficient P-Value 
Mean Lowest Highest 
*log(exp) 461 -67 988 0.087 
*Smoking_12 65 -17 148 0.118 
Depression -44 -98 10 0.111 
*log(physician) -724 -1217 -230 0.004 
*log(beds) 209 -171 589 0.279 
*log(LOS) -2762 -5000 -524 0.016 
CTMRI -10 -27 6.7 0.233 





Table 4-4. Multivariate Analysis with 7 Interactions 
Independent 
Variables 
Results (n = 230) *P-Value=0.000, R2=0.2289 
Coefficient P-Value 
Mean Lowest Highest 
*log(exp) 15686 -2925 34298 0.098 
*Smoking_12 -1337 -3137 463 0.145 
Depression 1859 533 3186 0.006 
*log(physician) 7227 -4347 18803 0.220 
*log(beds) 2920 -4052 9893 0.410 
*log(LOS) 21683 -41179 84547 0.497 
CTMRI 167 -165 499 0.322 
Check-up 1678 134 3222 0.033 
Exp*Smoking_12 130 -40 300 0.134 
Exp*Depression -179 -304 -54 0.005 
Exp*Log(Physi) -761 -1865 343 0.176 
Exp*Log(Beds) -249 -905 407 0.454 
Exp*Log(LOS) -2282 -8206 3643 0.449 
Exp*CTMRI -17 -50 16 0.311 







4-2-2) Final MLR Model 
In the final MLR model of overall healthcare Value in 230 communities, 1 
main independent variable (NHI expenditure) and 6 other independent variables 
- smoking rate in 2012, depression, number of physicians, number of beds, 
length of stay, and check-up rate, were selected.  To measure effect 
modifications between NHI expenditure and other independent variables, 4 
interaction terms – expenditure*smoking rate in 2012, expenditure*depression, 
expenditure *number of physician, and expenditure*check-up rate, were 
included in the final model.  
The overall p value of this model is 0.0000, and the overall explanatory 
capability (R2) is 22.15%.  In this model, 1 natural log of health expenditure 
increase is contributing to decrease the YPLLs-75 at a rate of 957421 between 2007 
and 2012 (p value = 0.023).  Also a 1% depression rate decrease is contributing to 
decrease the YPLLs-75 as 2041 between 2007 and 2012 (p value=0.002), and 1 
natural log of length of stay increase is contributing to increase the YPLLs-75 as 
2294 between 2007 and 2012 (p value = 0.042).  In the case of the check-up rate, a 
                                                          
21
 Although the natural log was used for Health Expenditures, 8665 represents the value of HSs with 
the averted YPLL-75 and the NHI health expenditures. 
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1 % higher rate for a community shows the 1419 decreased YPLLs-75 between 
2007 and 2012. (p value=0.021) 
Moreover, a 1% higher smoking rate produces an increase in YPLLs as  
1157 between 2007 and 2012, but the p-value is not significant (p value = 0.164).  
Also more physicians and beds produce a decrease of YPLLs as 9383 and 259, but 





Table 4-5. Multivariate Analysis with 4 Interactions 
(Final Model for Overall Healthcare) 
Independent 
Variables 
Results (n = 230) *P-Value=0.000, R2=0.2215 
Coefficient P-Value 
Mean Lowest Highest 
*log(exp) 9574 1311 17837 0.023 
*Smoking_12 -1157 -2793 478 0.164 
Depression 2041 760 3324 0.002 
*log(physician) 9383 -327 19093 0.058 
*log(beds) 259 -109 626 0.168 
*log(LOS) -2294 -4500 -88 0.042 
Check-up 1419 220 2617 0.021 
Exp*Smoking_12 114 -41 269 0.150 
Exp*Depression -196 -317 -76 0.002 
Exp*Log(Physi) -977 -1904 -31 0.039 

























9.5 10 10.5 11 11.5
ln_exp
lowess ypll_a ln_exp YPLL_A
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4-2-3) Effect Modification 
From the final model, the effect modifications for the 4 interaction terms – 
expenditure*smoking rate in 2012, expenditure*depression, expenditure 
*number of physician, and expenditure*check-up rate, are defined.   
First, higher smoking rate is contributing to an increase in the effect of 
health expenditures on the decrease of YPLLs between 2007 and 2012.  This 
means that in the higher smoking rate communities, the value of health 
expenditures for decreasing YPLLs is higher or better than in the lower smoking 
rate communities.  
Second, little progress in the depression rate from 2007 to 2012 is 
contributing to increasing the effect of health expenditures on the decrease of 
YPLLs between 2007 and 2012.  This means in the lower progress communities, 
the value of health expenditures for decreasing YPLLs is better than in 
communities where depression is improving. 
Third, a higher number of physicians are slightly associated with 
lowering the effect of health expenditures on the decrease of YPLLs between 
2007 and 2012.  This means that in the communities with higher numbers of 
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physicians, the value of health expenditures in decreasing YPLLs is slightly 
lower than in the communities with lower numbers of physicians. 
 Finally, lower check-up rates are contributing to increase the effect of 
health expenditures decreasing YPLLs between 2007 and 2012.  This means in the 
lower check-up rate communities, the value of health expenditures to the 








Coefficient (Value of HS) P-Value 
Mean Lowest Highest 
1) Low Smoking 
Rate Area: 
log(exp) 
659 190 1127 0.006 
2) High Smoking 
Rate Area: 
log(exp) 
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Coefficient (Value of HS) P-Value 
Mean Lowest Highest 
1) Low Progress 
Area: log(exp) 
1299 655 1943 0.000 
2) High Progress 
Area: log(exp) 
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Coefficient (Value of HS) P-Value 
Mean Lowest Highest 
1) Low Number 
Area: log(exp) 
824 135 1513 0.020 
2) High Number 
Area: log(exp) 
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Coefficient (Value of HS) P-Value 
Mean Lowest Highest 
1) Low Checkup 
Area: log(exp) 
1094 471 1717 0.001 
2) High Checkup 
Area: log(exp) 
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4-2-4) Analysis of Regional Characteristics 
To analyze the characteristics of the Seoul Metropolitan area and Non- 
Seoul Metropolitan area, both the values of HS for the separate Seoul 
Metropolitan (66 communities) and Non Seoul Metropolitan (164 communities)  
models were compared.  The value of HS in the Seoul Metropolitan model (14020) 
is better than in the Non-Seoul Metropolitan model (11681).  This result suggests 
that the NHI expenditure increase in the Seoul Metropolitan area is better in 
contributing to the decrease of YPLLs between 2007 and 2012 than in the Non-
Seoul Metropolitan area.  In the case of the Non-Seoul Metropolitan area model, 
the p-value is not significant. (p-value = 0.135) 
In addition, both the values of HS in the separate City area (145 
communities) and Rural area (85 communities) models were also compared.  The 
Value in the City model (8247) is lower than in the Rural model (13637). The 
result suggests that the NHI expenditure increase in the City area is lower in 
contributing to the decrease of YPLLs between 2007 and 2012 than in the Rural 
area.  But in the case of the rural area model, the p-value is not significant. (p-




Table 4-10. Value of HS: Seoul Metropolitan vs. Other Area 
Independent 
Variables 
Results (n = 230)  
Coefficient P-Value 
Mean Lowest Highest 
1) Seoul Metro 
Area: log(exp) 
* 66 communities 
14020 4002 24038 0.007 





11681 -3689 27052 0.135 
 
 
Table 4-11. Value of HS: City vs. Rural Area 
Independent 
Variables 
Results (n = 230)  
Coefficient P-Value 
Mean Lowest Highest 




8247 420 16075 0.039 
2) Rural Area: 
log(exp) 
* 85 communities 






4.3. Value of Cancer Care Services Model 
 
 4-3-1) Bivariate and Multivariate Analysis 
In the bivariate analyses between YPLLs for 5 cancers and each 
independent variable among 229 communities 22  (Table 4-12), among 33 
independent variables including the main independent variable (Cancer Care 
Expenditure) and 2 control variables (% female, % over age 65), 17 independent 
variables were selected for the next multivariate analyses since their P-values are 
higher than 0.300. (Table 4-12) 
From the exploratory analyses including the multi-collinearity analysis 
and the selection processes in the multivariate analyses, 8 independent variables 
were selected, including cancer care expenditure, income (NHI fee), smoking 
                                                          
22
 Among the 231 communities, 2 communities which are negative in the incremental expenditure for 
cancer care, were excluded since the communities would be extreme outliers in the analysis (see Figure 
11).  Also since I use the log transform of the incremental expenditure variable for the reason of normal 
distribution transformation, the negative values should be excluded automatically.  
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rate in 2012, hypertension, diabetes, stress, depression rate in 2012, and 
number of beds23. (Table 4-14)   
The Multivariate Analysis with 8 independent variables was also tested 





                                                          
23
  Among 229 communities, two extreme values (out-liars) in YPLLs are excluded in the exploratory 
analyses. And so the final model is constructed among 227 communities.  
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Table 4-12. Results of Bivariate Analyses for Cancer Care Services (n = 229) 
Independent 
Variables 
Results (n = 229) 
Coefficient P-Value 
Mean Lowest Highest 
expense -0.008 -0.040 0.023 0.610 
*log(exp) -25 -83 32 0.389 
apartment -0.63 -1.7 0.44 0.248 
Income -0.02 -0.05 0.01 0.245 
*log(NHI Fee) -30 -77 17 0.210 
Health Budget -0.22 -2.24 1.8 0.833 
*log(Budget) -11 -66 44 0.691 
Smoking -6.3 -14.7 2.2 0.146 
*Smoking_12 12.2 1.6 22.8 0.024 
Obesity 2.4 -5.5 10.3 0.549 
*Obesity_12 4.6 -5.0 14.3 0.345 
Hypertension -12.0 -23.2 -0.71 0.037 
*Hyper_12 15.8 3.7 27.8 0.011 
Diabetes -18.5 -36.4 -0.66 0.042 
*Diabetes_12 14.4 -7.4 36.3 0.194 
Stress 3.8 -0.4 7.9 0.076 
*Stress_12 -0.56 -6.5 5.4 0.852 
Depression -9.8 -17.1 -2.4 0.009 





Physicians -5 -18 7.8 0.443 
*log(physician) -14 -69 42 0.632 
Beds 0.4 -3.3 4 0.847 
*log(Beds) 21 -19 62 0.302 
LOS 3.6 -33 40 0.848 
*log(LOS) 16 -248 281 0.903 
Visit Days 1.1 -4.6 6.9 0.699 
*log(Visits) 31 -113 176 0.673 
CT/MRI -0.9 -2.7 1.0 0.370 
*log(CTMRI) -18 -40 4.9 0.123 
Check-up -0.9 -8.4 6.6 0.806 
*Check-up®  -5.3 -11 0.14 0.056 
Over 65 0.17 -3.4 3.8 0.926 
Female -13 -36 10 0.277 
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Table 4-13. Multivariate Analysis for Cancer Care Services with 17 variables 
Independent 
Variables 
Results (n = 229)  *P-value=0.0011, R2=0.1628 
Coefficient P-Value 
Mean Lowest Highest 
*log(exp) -95 -167 -22 0.010 
apartment -2.7 -5.7 0.25 0.072 
*log(NHI Fee) -22 -81 37 0.465 
Smoking 1.6 -9.4 12.6 0.775 
*Smoking_12 6 -8.1 20.2 0.401 
Hypertension -5.8 -21.7 10.2 0.477 
*Hyper_12 2.4 -17.9 22.7 0.814 
Diabetes -7.0 -38 24 0.654 
*Diabetes_12 -11 -50 28 0.569 
Stress 5.9 1.2 11 0.014 
Depression -14.9 -25.7 -4.1 0.007 
*Depress_12 -1.4 -22 20 0.895 
*log(Beds) 58 -19 62 0.302 
Check-up -13 -24 -2 0.019 
Physician -2.2 -13 9 0.711 
Over 65 -13 -24 -2.4 0.017 





Table 4-14. Multivariate Analysis for Cancer Care Services with 8 independent 




Results (n = 227)  *P-value=0.0156, R2=0.0818 
Coefficient P-Value 
Mean Lowest Highest 
*log(exp) -43 -104 17 0.162 
*log(NHI Fee) -27 -77 23 0.290 
*Smoking_12 9.5 -1.5 21 0.091 
Hypertension -6.1 -19 6.8 0.352 
Diabetes -13.9 -34 6.6 0.182 
Stress 3.9 -0.4 8 0.014 
*Depress_12 9.4 -3.9 23 0.166 






Table 4-15. Multivariate Analysis for Cancer Care Services with 6 Interactions 
Independent 
Variables 
Results (n = 227)  *P-value=0.0039, R2=0.1368 
Coefficient P-Value 
Mean Lowest Highest 
*log(exp) -290 -1326 746 0.582 
*log(NHI Fee) 249 -672 1171 0.594 
*Smoking_12 -41 -219 136 0.647 
Hypertension 218 32 405 0.022 
Diabetes -13 -33 7.3 0.207 
Stress -10.6 -69 48 0.723 
*Depress_12 -248 -498 1.3 0.051 
*log(Beds) -242 -987 504 0.523 
Exp*Log(NHI fee) -37 -163 88 0.558 
Exp*Smoking_12 7 -17 31 0.568 
Exp*Hyper -30 -55 -5 0.019 
Exp*Stress 2 -5.9 9.9 0.622 
Exp*Depress_12 34 1.2 68 0.042 








4-3-2) Final MLR Model for Cancer Care Services 
In the final MLR model for cancer care in 227 communities, 1 main 
independent variable (cancer care expenditure) and 6 other independent 
variables - income (NHI fee), smoking rate in 2012, hypertension, diabetes, 
stress, depression rate in 2012, and number of beds-- were selected.  To measure 
effect modifications between the cancer care expenditures and other independent 
variables, 2 interaction terms – expenditure*hypertension, expenditure* 
depression rate in 2012 - were included in the final model.  
The overall p value of this model is 0.0005, and the overall explanatory 
capability (R2) is 12.66%.  In this model, 1 natural log of cancer expenditure 
increase results in the increase of YPLLs-75 as 293 between 2007 and 2012 (p 
value = 0.001).  Also a 1% decrease in hypertension and stress rates are associated 
with decreases in YPLLs-75 as 192 and 4.4 between 2007 and 2012 (p value=0.035, 
0,039), and a 1% higher depression rate in 2012 is associated with an increase in 
the YPLLs-75 as 277 between 2007 and 2012 (p value = 0.023).  
Moreover, a 1% higher smoking rate in 2012 and 1% diabetes rate 
increase is associated with the decrease of YPLLs as 8.8 and 13 between 2007 and 
2012, but the p-value is not significant (p value = 0.109 and 0.190).  Also more 
124 
 










Results (n = 227)  *P-value=0.0005, R2=0.1266 
Coefficient P-Value 
Mean Lowest Highest 
*log(exp) -293 -415 -112 0.001 
*Smoking_12 8.8 -2.0 20 0.109 
Hypertension 192 13 370 0.035 
Diabetes -13 -33 6.7 0.190 
Stress 4.4 0.22 8.7 0.039 
*Depress_12 -277 -515 -39 0.023 
*log(Beds) 35 -7.3 78 0.104 
Exp*Hyper -27 -50 -2.8 0.029 

























5 6 7 8 9
ln_exp_c
lowess ypll_5c ln_exp_c YPLL_5C
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4-3-3) Effect Modification 
In the final model, the effect modifications in the 2 interaction terms – 
expenditure*hypertension, expenditure* depression rate in 2012 - were 
examined.   
First, more improvement in the hypertension rate from 2007 to 2012 is 
associated with less effect of health expenditures on the decrease of YPLLs 
between 2007 and 2012.  This means that in the higher progress communities in 
terms of the hypertension rate, the value of cancer care expenditures to the 
decrease of YPLL is worse than in the lower progress communities. But in the 
case of both higher and lower progress models, the p-values are not significant. 
(p-value = 0.169 and 0.943) 
Second, a higher depression rate is associated with an increase in the 
effect of health expenditures on the decrease of YPLLs between 2007 and 2012.  
This means that in the communities with higher depression rates, the value of 
cancer care expenditure to the decrease of YPLLs is better than in the lower 
depression rate communities.  But in the case of both higher and lower rate 
models, the p-values are not significant. (p-value = 0.253 and 0.063) 
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Table 4-17. Interaction by Progress in Hypertension Rates 
Independent 
Variables 
Results (n = 227)  
Coefficient P-Value 
Mean Lowest Highest 
1) Low Progress 
Area: log(exp) 
-3.2 -92 86 0.943 
2) High Progress 
Area: log(exp) 
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Table 4-18. Interaction by Depression Rates 
Independent 
Variables 
Results (n = 227)  
Coefficient P-Value 
Mean Lowest Highest 
1) Low Rate 
Area: log(exp) 
-77 -159 4.2 0.063 
2) High Rate 
Area: log(exp) 
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4-3-4) Analysis of Regional Characteristics 
To compare the characteristics of the Seoul Metropolitan area and the 
Non-Seoul Metropolitan area for cancer care, both the values of HS in the 
separate Seoul Metropolitan (66 communities) and Non-Seoul Metropolitan (161 
communities) models were compared.  The value in the Seoul Metropolitan 
model (-177) is relatively better than in the Non-Seoul Metropolitan model (-244).  
This result suggests that the cancer care expenditure increase in the Seoul 
Metropolitan area resulted in relatively less increase of YPLLs between 2007 and 
2012 than in the Non-Seoul Metropolitan area.  In case of the Seoul Metropolitan 
area model, the p-value is not significant. (p-value = 0.331) 
In addition, both the values of HS in the separate City area (144 
communities) and Rural area (83 communities) models were also compared.  The 
value in the City model (-78) is better than in the Rural model (-556).  The result 
suggests that the cancer care expenditure increase in the City area is resulting in 
relatively less increase of YPLLs between 2007 and 2012 than in the Rural area.  




Table 4-19. Value of HE: Seoul Metropolitan vs. Other Area 
Independent 
Variables 
Results (n = 227)  
Coefficient P-Value 
Mean Lowest Highest 
1) Seoul Metro 
Area: log(exp) 
* 66 communities 
-177 -537 184 0.331 





-244 -442 -46 0.016 
 
 
Table 4-20. Value of HE: City vs. Rural Area 
Independent 
Variables 
Results (n = 227)  
Coefficient P-Value 
Mean Lowest Highest 




-78 -238 82 0.039 
2) Rural Area: 
log(exp) 
* 83 communities 





4.4. Value of Mental Health Care Services Model 
 
4-4-1) Bivariate and Multivariate Analysis 
In the Bivariate analysis, all the independent variables were tested to find 
any individual relationship with the averted YPLLs-75 due to suicides at the 
local community level.  But overall the P-values are much higher than 0.300 
except for 5 independent variables – Beds, Obesity, Hypertension, Diabetes, and 
Stress rate in 2012.  The Multivariate Analysis with the mental health care 
expenditures increase and those 5 independent variables was also examined. 
Both in the Bivariate and Multivariate Analysis, the potential 
relationships between the averted YPLLs-75 and the mental health care 
expenditures increase from 2007 to 2012, were not significant, and many p-values 
for the relationships were large. (0.644, 0.773)  These results suggest that there is 
no significant YPLLs decrease in Suicides between 2007 and 2012 although the 
mental health care expenditures by the NHI were increased from 2007 and 2012.  
The value of mental health care services in this model based on the multivariate 
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analysis could not be demonstrated in this exploratory analysis of the local 
mental health care services.  
As an alternative approach, Longitudinal Analyses (LDA) were tested to 
examine relationships at the local community level between the level of YPLL by 





Table 4-21. Results of Bivariate Analyses for Mental Health Services (n = 230) 
Independent 
Variables 
Results (n = 230) 
Coefficient P-Value 
Mean Lowest Highest 
Mental 
expenditure 
0.00005 -0.016 0.016 0.995 
*log(mental 
exp) 
15 -48 78 0.644 
apartment 0.19 -1.3 1.7 0.796 
Income -0.009 -0.049 0.03 0.646 
*log(NHI Fee) 9.6 -55 74 0.770 
Health Budget -0.78 -3.6 2.0 0.579 
*log(Budget) -12.8 -88 62 0.737 
Smoking 3.1 -8.6 14.8 0.599 
*Smoking_12 2.3 -12.5 17.1 0.760 
Obesity 7.6 -3.2 18 0.169 
*Obesity_12 -1.2 -14 12 0.856 
Hypertension 11 -4.3 27 0.158 
*Hyper_12 -5.6 -22 11 0.511 
Diabetes 16 -8.6 41 0.202 
*Diabetes_12 -15 -45 15 0.317 
Stress 0.6 -5.2 6.3 0.849 




Depression 3.0 -7.3 13.3 0.564 
*Depress_12 2.3 -16 20 0.800 
Physicians 3.8 -13.9 22 0.669 
*log(physician) -8.6 -85 68 0.826 
Beds 4.7 -0.3 9.6 0.065 
LOS 1.3 -49 51 0.959 
*log(LOS) 4.6 -358 367 0.980 
Visit Days 0.65 -7.3 8.6 0.871 
*log(Visits) 27 -173 226 0.790 
CT/MRI -0.37 -2.97 2.2 0.781 
*log(CTMRI) -20.4 -53 12 0.213 
Check-up -0.20 -10.5 10.1 0.970 
*Check-up®  3.3 -4.3 10.9 0.389 
Over 65 -0.11 -5 4.8 0.964 
Female 2.0 -30 34 0.899 
Seoulmetro 70 -9.6 150 0.084 
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Table 4-22. Multivariate Analysis with 6 variables 
Independent 
Variables 
Results (n = 230)  *P-value=0.2034, R2=0.0371 
Coefficient P-Value 
Mean Lowest Highest 
*log(mental exp) 11.6 -67 90 0.773 
Beds 4.1 -1.6 9.8 0.157 
Obesity 8.1 -3.2 19.5 0.159 
Hypertension 4.4 -13.5 22 0.630 
Diabetes 9.1 -18.5 37 0.518 
























6 7 8 9 10
ln_exp_m
lowess ypll_s ln_exp_m YPLL_S
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4-4-2) Longitudinal Analysis (LDA) 
Longitudinal Analyses (LDA) were designed to examine relationships at the 
local community level between the level of YPLL by suicides and the level of 
mental health care expenditures both in 2007 and in 2012.  Based on Multivariate 
Analysis with the 8 independent variables24 including the main variable – mental 
health care expenditures, a categorical variable regarding year – 2007 or 2012, 
was added to the model to perform the Longitudinal Analyses (LDA).  To test 
the characteristics of Seoul Metropolitan Area and City Area, these two 
categorical variables were added to the model as well. 
Among 11 independent variables, including the main independent 
variable (Mental Health Care Expenditure) and 1 control variables (% female), 
Hypertension was excluded after the bivariate analysis since the P-value (0.613) 
was higher than 0.05. 
Following the Multi-collinearity analysis, Depression and Seoul-Metro 
area were excluded since the two independent variables showed high multi-
collinearity with other independent variables.  A Multivariate Analysis with 8 
                                                          
24
 In this Longitudinal Analysis, the variables obtained for both years – 2007 and 2012 were used, and 
the numbers of all samples were 462. (231 communities for each year) 
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independent variables was tested with a selection process to finalize the LDA 




Table 4-23. Bivariate Analysis with 11 variables for LDA 
Independent 
Variables 
Results (n = 462) 
Coefficient P-Value 
Mean Lowest Highest 
Mental Exp 0.016 0.011 0.022 0.000 
*log(Exp) 132 92 172 0.000 
Smoking 12 4.3 20 0.003 
Obesity 16 9.2 23 0.000 
Hypertension 2.4 -6.8 12 0.613 
Diabetes 21 3.5 39 0.020 
Stress -4.2 -8.7 0.31 0.068 
Depression -8.1 -16 0.04 0.051 
Year 68 22 114 0.004 
Seoul-metro 146 96 196 0.000 
City 166 120 212 0.000 





4-4-3) Final MLR (LDA) Model 
In the final MLR(LDA) model of Mental Health Care (Table 4-24), one 
main independent variable (natural log of mental care expenditures) and 5 other 
independent variables were selected – the Smoking Rate, the Obesity Rate, City, 
Year, and Female.  The overall p value of the model is 0.0000, and the overall 
explanatory capability (R2) is about 17%.   
First, 1 natural log of Mental care expenditure increase is associated with 
an increase of the YPLL as 105 (p value = 0.001) among communities.  This 
suggests that the mental health care expenditure increase is not effective in terms 
of a YPLL decrease or Suicide decrease at the local community level in Korea.  
Second, a 1% smoking rate increase is associated with a significant  
YPLLs increase by suicide (p value = 0.006), and a 1% obesity rate increase is 
associated with a significant increase in YPLLs by suicide (p = 0.033).  Also in the 
rural area, YPLLs by suicide are 105 higher than in the city area. (p = 0.000) 
Finally, the year change from 2007 to 2012 results in 13 YPLLs decrease 
by suicide, but it’s not significant. (p = 0.711)  The %female variable also did not 
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show any significant relationship with the level of YPLLs by suicide at the local 




Table 4-24. Final Multivariate Analysis for LDA 
Independent 
Variables 
Results (n = 462)  *p value=0.000 (R2=0.1671) 
Coefficient P-Value 
Mean Lowest Highest 
*log(Mental 
Exp) 
105 42 169 0.001 
Smoking 12 3.4 20 0.006 
Obesity 9.0 0.7 17 0.033 
Year -13 -80 54 0.711 
City 105 49 161 0.000 
Female -6.4 -30 17 0.595 
 


















7.5 8 8.5 9 9.5 10
ln_exp_mental
lowess suicide ln_exp_mental Suicide
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Table 4-25. Summary of Study Results 
1) Effects of NHI Health Expenditure Increase on the averted YPLLs 
Healthcare 
Services 
Effects of NHI Health Expenditure (NHI HE) Increase 
Increase of NHI HE 
(’07-’12) 
Higher Increase of NHI HE 
 among communities (’07-’12) 
Overall Positive averted YPLLs Higher averted YPLLs 
Cancer Positive averted YPLLs Lower averted YPLLs 
Mental Health25 Increased YPLLs by Suicides 
 
2) Other Determinants of Health Contributing to More Averted YPLLs 
Healthcare 
Services 
Other Determinants of Health 
Overall Decrease of Depression Rate 
Lower LOS 
Higher Check-up Rate 
Higher Physician Rate 
Cancer Decrease of Hypertension Rate 
Decrease of Stress Rate 
Lower Depression Rate 
Mental Health Higher Smoking Rate (→ More YPLLs by Suicides) 
Higher Obesity Rate (→ More YPLLs by Suicides) 
 
                                                          
25








Overall Communities with Higher Smoking Rates 
Communities with Lower Progress in Depression Rates 
Communities with Lower Physician Rates 
Communities with Lower Check-up Rates  
Cancer Communities with Lower Progress in Hypertension Rates 
Communities with Higher Depression Rates 
Mental Health - 
 




Overall Seoul Metro Area (Higher Value) 
City Area (Lower Value) 
Cancer Non-Seoul Metro Area (Lower Value) 
City Area (Higher Value) 





Chapter 5: Discussion of Results and Implications 
 
5.1. Discussion of Study Results 
First, with the traditional value analyses based just on the relationship 
between the NHI HE increase and the averted YPLLs, we can tentatively 
conclude that in the overall and cancer care services, the NHI HE increase from 
2007 to 2012 is associated with the averted YPLLs from 2007 to 2012.  However 
the  value ratios (NHI HE increase per 1 YPLL decrease) varied by communities 
and there was no specific threshold (ceiling ratio) to indicate if the ratios showed 
good values for money for achieving the adequate value of local health services 
under the NHI system in South Korea.  
But in the mental health care services, I could not conclude if the NHI HE 
increase from 2007 to 2012 contributed to the averted YPLLs by suicides or not, 
since about 40% of all the communities showed an increase of YPLLs by suicides 
between 2007 and 2012 regardless of the NHI HE increase in the mental health 
care services between 2007 and 2012.  
147 
 
More specifically, from the main MLR analyses which expanded the 
number of independent variables from only the NHI expenditures to the 
additional 16 determinants of health at the local community level, I could find 
that there were various determinants of health which modified the values of HS 
as well as affecting the averted YPLLs directly.   Also in the case of the values of 
HS adjusted by various determinants of health, the value ratios between the 
averted YPLLs and the NHI HE were somewhat different from the results of the 
traditional value analyses which didn’t control for the effects of other health 
determinants on the averted YPLLs.  
The discussion of the results of the main MLR analyses for the 3 health care 
services – overall, cancer, and mental health care are summarized below. 
 
5-1-1) Overall Healthcare Services in South Korea 
From the final MLR model of the value of HS in overall healthcare, it was 
found that the communities with bigger increases in the NHI HE showed better 
health outcomes in terms of the averted YPLLs compared with the communities 
with smaller increases in the NHI HE between 2007 and 2012.   Considering that 
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the NHI HE increase means more utilization of NHI healthcare services, it can be 
concluded that the allocation of financial resources under Korea’s NHI system at 
the local community level was associated with better health outcomes in terms of 
reducing premature death before age 75 between 2007 and 2012. 
Regardless of the level of NHI HE for the overall healthcare, the 
communities with more improvement in the depression rate, a higher physician 
to population ratio, and higher check-up rate on average also showed more 
improvement in the averted YPLLs from 2007 to 2012.  In contrast, the 
communities with longer average hospital LOS showed worse health outcomes 
in terms of the YPLLs-75 increase compared with the communities with shorter 
average LOS.  Although it was not statistically significant, the communities with 
a higher number of hospital beds and lower smoking rates also showed higher 
decreases of YPLLs between 2007 and 2012.  
Although these results regarding the relationship between specific 
determinants of health and the averted YPLLs should be tested at the individual 
level in follow-up studies, these results suggest that certain health determinants 
in terms of better health resources and individual biological factors might 
directly affect the variations of YPLLs at the local community level regardless of 
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the level of NHI HE.  It can also be inferred that better health resources on 
average in terms of more physicians and more check-ups, and better 
improvement in mental health on average might be associated with better health 
outcomes in terms of less premature deaths at the local community level in South 
Korea.  But there are certain limitations that need to be mentioned regarding the 
relationship between the specific determinants and the averted YPLLs from these 
study results since this study is a meso-level study based on the community level 
data as the unit of analysis. 
From the final MLR model of overall healthcare, it was also found that some 
health determinants result in an effect modification on the value of HS 
expenditures on averted YPLLs.  In the communities with lower physician rates, 
higher smoking rates (not statistically significant), lower improvement in 
depression rates, and lower check-up rates, this study showed that the value of 
HS improved.   In fact, in the communities with lower health status and 
resources on average in terms of physician rates, depression, smoking, and 
check-up rates, the values of HS showed better ratios than in the communities 
with better health status and resources on average.   
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From these results with regards to the modification of the value of HS, it 
can be inferred that the value of HS for the overall healthcare might be less in the 
relatively high health performance communities on average.  This result might 
also imply that in the relatively high health performance areas, there might be 
inefficient or excessive utilization of HS due to the NHI benefits without 
improving health outcomes in terms of less premature deaths. 
According to the analysis of the regional characteristics for the overall 
healthcare services, in the Seoul Metropolitan Area, the association between 
YPLLs and NHI expenditures showed higher value compared with the non-
Seoul Metropolitan Area.  This might imply that the Seoul Metropolitan Area has 
a relatively efficient health care system compared with the non-Seoul 
Metropolitan Area on average.  Also in the Rural Area, the value of HS was 
better compared with the City Area, although it was not statistically significant. 
Generally speaking, relatively underdeveloped areas like the non-Seoul 
metropolitan area and rural areas might have relatively larger efficiency gaps in 
their health care systems.  And so it might be inferred that the return on 
investment for NHI expenditures on the health performance might be lower in 
the underdeveloped areas.  But this study showed unclear results for the rural 
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areas.  More studies on these gaps and variations at the local community level 
should be conducted in the future. 
 
5-1-2) Cancer Care Services in South Korea 
From the final MLR model on the value of HS in cancer care, it might be 
assessed that the communities with larger increases in NHI cancer expenditures 
had worse health outcomes in terms of the averted YPLLs compared with the 
communities with smaller increases in the NHI cancer expenditures.   
Considering that an NHI cancer expenditure increase means more utilization of 
NHI cancer care services, it can be assessed that the allocation of financial 
resources under Korea’s NHI cancer care system wasn’t associated with better 
health outcomes in terms of reducing premature death between 2007 and 2012 at 
the local community level in South Korea. 
This result is quite interesting and surprising because most communities 
showed fewer premature deaths by the 5 cancers when NHI cancer expenditures 
were increased from 2007 to 2012 in the traditional value of HS analysis just 
considering two variables – the averted YPLLs and NHI cancer expenditures.  
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This result suggests that as the NHI cancer expenditure were increasing among 
communities, the averted YPLLs-75 were decreasing, although the NHI cancer 
expenditure increases were associated with fewer premature deaths by cancers in 
most communities from 2007 to 2012.   
Regardless of the NHI cancer expenditure increases, the communities with 
more improvement in hypertension and stress rates, and lower depression rates 
showed better progress in the averted YPLLs from 2007 to 2012.  It was also 
found that the communities with higher numbers of hospital beds to total local 
population and higher smoking rates in 2012 had larger decreases of YPLLs 
between 2007 and 2012, but these associations were not statistically significant.  
The communities with more improvement in diabetes rates between 2007 and 
2012 showed higher increases of YPLLs between 2007 and 2012, but this was not 
statistically significant either. 
Although these results regarding the relationships between specific 
determinants of health and the averted YPLLs in cancer care should be tested at 
the individual patient level in follow-up studies, these results might imply that 
certain health determinants in terms of better biological and psychological 
factors might directly affect the variations of YPLLs at the local community level 
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regardless of the level of NHI HE in cancer cares.  It can also be inferred that 
more improvement in health status including mental health might contribute to 
better health performance in terms of less premature deaths by cancers.   
Although these results may suggest the importance of better management 
of biological and psychological health factors including stress and depression for 
cancer care outcomes regardless of the NHI cancer expenditures, there are 
limitations that should be mentioned.  The relationships between the specific 
health determinants and the averted YPLLs from cancers based on these study 
results must be viewed with caution since this study is a meso-level study based 
on the aggregate data at the local community level as the unit of analysis.  But it 
can be inferred that the averted YPLLs by cancers between 2007 and 2012 might 
not be caused by the NHI cancer expenditure increases, but by other 
determinants of health including better management and promotion of biological 
and psychological factors at the local community level in South Korea.  
From the final MLR model for cancer care, it was also found that some 
health determinants resulted in the effect modification on the value of HS for 
cancer care.  In the communities with increased hypertension rates from 2007 to 
2012 and bigger depression rates in 2012, the negative effects of NHI cancer care 
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expenditure increases on the averted YPLLs by cancers were less.   This implies 
that in the communities with lower health performance in terms of hypertension 
and depression, the value of HS for cancer care might show better outcomes.  
This result is in line with the case of overall HS so that there is a possibility that 
the return of NHI HE investment on relatively poor health performance 
communities might get bigger on average compared with high health 
performance communities. 
According to the analysis of the regional characteristics for cancer care 
services, in the non-Seoul Metropolitan Area and rural areas, it was found that 
the value of HS for cancer care decreased.  This might imply that in the case of 
cancer treatment under the NHI system, underdeveloped areas could show 
relatively less value of HS and more negative returns on investment.  This is 
possibly due to certain environmental health factors like poor transportation 
between home and cancer centers and so they might tend to stay longer or use 
more or excessive services in cancer centers on average.  But more studies on this 
should be conducted in the future. 
In addition, significant relationships were not found between the value of 
HS in cancer care and some other health utilization variables like number of 
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physicians, number of high priced health equipment, LOS, and number of 
hospital visits at the local community level. 
 
5-1-3) Mental Health Care Services in South Korea 
From the traditional (bivariate) value analysis of mental health care services, 
it was found that the increase in the NHI HE between 2007 and 2012 may not be 
associated with the averted YPLLs by suicides between 2007 and 2012.  Although 
the mental care expenditures increased between 2007 and 2012, the YPLLs by 
suicides have also increased in nearly 40% of all the communities between 2007 
and 2012. And therefore Korea’s mental HE or mental health services under the 
NHI system might not be effective in decreasing YPLLs by suicides between 2007 
and 2012. 
Both in the Bivariate and Multivariate Analyses of the values of HS in 
mental health care, no potential relationships between the averted YPLLs-75 by 
suicides and the mental HE increase from 2007 to 2012, were found.  But a LDA 
analysis was also performed of the relationships between the levels of YPLLs by 
suicides and possible health determinants including the NHI mental HE at the 
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local community level.  Based on the LDA model, including both 2007 and 2012 
data, it was found that the communities with higher NHI mental HE, higher 
smoking rates to total local population, and higher obesity rates to total 
population showed higher YPLLs by suicides.  The year change between 2007 
and 2012 didn’t show any significant influence on the level of YPLLs by suicide 
which is in line with the value analysis and the MLR analysis on the value of HS 
in mental health care. 
In South Korea, it is quite surprising that the communities with the higher 
NHI mental HE had more premature deaths by suicides both in 2007 and in 2012.  
This result is in line with the result of the traditional value analysis on the value 
ratios between the mental HE and the averted YPLLs by suicides as we’ve 
discussed previously. 
Moreover, it might also be of interest that certain behavioral and biological 
factors like smoking and obesity could have relationships with the averted 
YPLLs by suicides at the local community level.  Although these results on the 
relationship between specific determinants of health and the averted YPLLs by 
suicides should be tested at the individual level in follow-up studies, these 
results show that there are some possibilities that worse behavioral and 
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biological status on average might be associated with certain psychological 
processes leading to more and younger deaths by suicides.  More studies on 
these possibilities should be conducted in the future. 
In the case of the City areas analysis, it was also found that the YPLLs by 
suicide were larger than those in rural areas.  It might be interpreted that in the 
case of mental health care, city areas are more vulnerable to suicides, possibly 
due to psychological factors like highly competitive environments and 
workplaces in modern society.  More studies on this should be conducted in the 
future as well. 
 
5-1-4) Conclusion 
Overall, the recently increased NHI HE at the local community level was 
associated with a decrease of premature deaths under the Korean NHI system.  
But the regional variations in the values of HS were somewhat large.  Specifically, 
when the various determinants of health were considered and controlled in the 
MLR model, the influences of the NHI HE increases on the health outcomes (the 
averted YPLLs) were very limited.  More specifically it was found that in the 
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very important healthcare service areas like cancer care and mental health care, 
the values of HS showed negative ratios and diminishing trends as the NHI HE 
increased among communities.   
Regardless of NHI HE’s increases, certain determinants of health including 
some biological and behavioral factors, affected the health outcomes directly and 
modified the values of NHI HE as well.  Therefore, improving the indicators of 
biological and behavioral health status might be very important in South Korea 
in order to improve health outcomes in terms of YPLLs at the local community 
level.  
Low health performance areas due to certain biological and psychological 
factors, showed higher value of HS both in overall healthcare and cancer care 
services.  This might imply that health policies in terms of NHI HE should target 
the areas with lower health performance in the context of return on investment 
as well as equity.  More targeted health policy under the NHI system should be 





5.2. Policy Implications and Recommendations 
This meso level study suggests that the local community level might be 
useful as a unit of analysis to assess present NHI HE policy and their outcomes, 
and therefore, to design more focused and efficient local health policies in Korea.  
This study can also be a first step to determine potential health predictors which 
can help explain and affect regional disparities and variations in the value of HS 
and health outcomes at the local community level in Korea. 
From this meso-level study on the value of HS under the Korean NHI 
system, it might be inferred that the effects of HE increases on premature death 
are limited and vary significantly at the local community level.  In fact, at the 
country level analysis on the value of HS, the results showed all positive effects 
of HE increases on premature death – Overall (Averted YPLLs: 444,366, HE 
increase: 9.4 trillion KRW), Cancer (Averted YPLLs: 66,037, HE increase: 413 
billion KRW), Suicide (Averted YPLLs: 8351, HE increase: 843 billion KRW).  But 
these meso-level study results showed that in the cases of cancer and mental 
health care, there were negative value ratios which might imply that the 
increased HE did not contribute to the averted YPLLs between 2007 and 2012 at 
the local community level.  This study also showed that there are strong 
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possibilities that certain health determinants in terms of biological and 
behavioral factors might directly affect the averted YPLLs at the local community 
level regardless of the level of NHI HE.  This result suggests that the effects of 
NHI HE by itself might have some limitations with regard to increasing health 
outcomes at the local community level, and so other public health policies to 
manage determinants of health should be addressed to improve health outcomes 
as well.  Therefore, policy efforts to manage determinants of health at the local 
community level as well as to make the NHI system more efficient should be 
emphasized simultaneously in the future. 
Another important implication of this study is that in the already high 
health performance communities, the value of HS might be lower than in the 
relatively poor health performance communities.  In the perspective of value for 
money spent as well as equity, this might suggest that more financial resources 
should be allocated to the relatively poor health performance communities under 
the Korean NHI system. 
Moreover, this study might provide important policy implications that 
simple health policies to increase NHI benefits for certain medical services may 
not be able to produce the improvement of health outcomes and performance 
161 
 
substantially.  Especially, in terms of the value of HS perspective, the simple 
benefit increase policy for high priced medical services without suitable value 
analyses may not result in desirable health outcomes at the local community 
level in Korea.  Therefore, from this study, other efficient ways, like better 
management of behavioral and biological health factors before implementing 
benefit increases in NHI policy, should be emphasized for the improvement of 
local health outcomes in order to produce higher value of HS at the local 
community level in Korea.  A recent study also pointed out that in the advanced 
countries with already high life expectancies, further progress in the life 
expectancies might not be explained by more medical care resources but by 
better management of social determinants on chronic and non-communicable 
diseases. (Bishai & O’Neil, 2012)   
Based on these policy implications, some important future health policy 
recommendations are summarized in the next sections. 
 
5-2-1) Introduction of Periodic Assessment of the Value of NHI HE 
Generally speaking, the increasing cost of medical care, limited financial 
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resources, and excessive and inappropriate utilization of high priced healthcare 
services and technologies are leading to debates on limiting healthcare services 
based on the associated health outcomes and values.   Korea is not an exception.  
Therefore, it might be very useful to follow up on the assessment of outcomes 
and value of NHI HE periodically at the local community level in the future to 
optimize the outcomes of local health services together with the adoption of new 
high-priced medicines and treatment technologies in Korea.   
The assessment could be expanded to various specific disease services and 
different age groups to obtain more information on the values of NHI HS.  
Although overall the NHI HS have contributed to better health outcomes and 
higher values at the local community level, the assessment of the various specific 
HS like cancer care, preventive care, and chronic care might not be efficient.  And 
therefore the allocation of financial resources under the NHI system for different 
disease services and different age groups could be redesigned in the future based 
on their value assessment in order to increase their values for money spent in the 
NHI HS in terms of less premature death.  This approach will make the NHI HS 




The main decision making on the coverage of certain medical services in the 
NHI benefit package should also be based on needs, effectiveness, safety, and 
costs.  Sometimes, our political system doesn’t allow reasonable discussion or 
decision-making processes here.  The Korean government should be careful 
about the analyses of value assessment on NHI HE and the decision-making on 
the expansion of NHI benefits should be based on the results of reasonable value 
assessment and cost-effectiveness analysis, not by political philosophies and 
interests.  (Rice & Unruh, 2009, p.365-367)  
 
5-2-2) Public Health Policies to Manage Biological and Behavioral Factors 
Considering that the NHI HS alone have certain limitations to produce 
better health outcomes and higher values, various health policies to manage the 
determinants of health including biological and behavioral health factors should 
be more emphasized in order to produce better health outcomes and higher 
value of HS at the local community level.  While there are many debates about 
how much medical service can contribute to increase the life expectancy or other 
health outcomes, a lot of experts have suggested that better management of 
health determinants including preventing and controlling health risk factors can 
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directly contribute to less premature death under the NHI system regardless of 
the level of NHI HE. 
According to a National Health Services (NHS) case study in the UK, most 
of the annual NHS expenditures to treat the patients with diabetes are used up 
by the costs of treating life-threatening complications which are the result of a 
failure to keep a patient’s diabetes under control.  Noting that the NHS will face 
a tremendous financial deficit in the diabetes treatment in the near future 
without a radical shift, now the NHS is attempting to change from hospital based 
care to preventing and controlling diabetes. (Financial Times, 2014) 
Above all else, the NHIC and MOHW in Korea should provide more 
incentives for local healthcare institutions which operate better preventive 
services, and consider more insurance benefits at the local level for patients who 
manage their health risk factors well in the primary community health centers 
under the NHI system.  Local government should also highlight various health 
promotion and education programs at the local community level which could 





5-2-3) Innovation in the Cancer and Mental Health Care Systems under NHI 
Considering the negative values of HS for cancer and mental health care in 
spite of the big increases in NHI HE between 2007 and 2012, cancer and mental 
health care systems in Korea may need to be reformed in the near future. 
In the case of cancer care, many experts have pointed out that inpatient 
services based cancer care in Korea should be transformed to outpatient services 
based cancer care and recovery services in primary health centers or long term 
care centers in the local communities.  But more generous NHI benefit policies 
might incentivize cancer patients to stay longer and get more inpatient services 
in hospitals.  Although more studies on the inefficiency of cancer care in Korea 
should be conducted, certain policy directions which could increase the value of 
HS in cancer care should be considered by the NHIC and MOHW in the future.  
Similar problems also have been pointed out in the mental health care 
system in Korea.  According to a recent report from OECD, Korea is the only 
OECD country where the numbers of mental health care beds have increased 
steadily.  They also pointed out that more mental health care beds and 
psychiatric hospitals have been used to treat less acute mental problems with 
longer stays and so hospitalized treatment in mental health care is too much of a 
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general trend in Korea, while most OECD countries usually manage mental 
health diseases in community settings, not in the hospital settings. (OECD, 2014)  
The hospital based treatment in mental health care with traditionally negative 
stigma in Korea might tend to move a lot of potential patients with mental illness 
away from mental health treatment at the local community level.  In this context, 
these analyses can have very important implications for the direction of mental 
health care innovations to increase the value of HS in the Korean mental health 
care system. 
 
5-2-4) More Targeted Health Policy for Low Health Performance Communities 
 These study results also suggest that in the low health performance 
communities in terms of certain behavioral and biological factors like smoking, 
hypertension, and depression rates, the value of every dollar spent in the NHI 
HS might be larger than in the high health performance communities.  This result 
could be well supported by political interests in terms of the equity perspective.  
And therefore in the case of low health performance communities, health policies 
to increase access and exposure to NHI HS as well as more generous NHI 
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benefits focusing on those communities might be more effective in producing 
fewer premature deaths in Korea.   
To increase access to care and utilization of NHI HS in the relatively poor 
health performance communities, the NHIC, MOHW, and local governments 
should implement various policy measures to build up well-functioning local 
community healthcare systems in those areas.  Using well-advanced information 
technology in Korea might be a cost-effective option to increase access to the NHI 
healthcare services as well.  
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5. 3. Limitations 
Regardless of the policy implications and recommendations, several 
limitations in this study should be mentioned. 
First, this study used the averted YPLLs as the health outcome based on the 
premature death alone, but did not consider change in disabilities or quality of 
life.  As we have seen in the literature review, a well-known method to measure 
the change in disabilities is the DALYs method.  Since measuring the 
improvement in disabilities as a result of healthcare services depends on 
individual perceptions of disabilities or suffering, the DALYs method also has 
certain limitations in generalizability.  At this point, reliable data on DALYs and 
YLDs (Years Lived with Disabilities) are not available at the local community 
level in Korea, and the DALYs method itself is still debated among researchers 
regarding how to calculate specifically in Korea as well.  But since there must be 
improvement in disabilities or suffering as a result of healthcare services, this 
study on the health outcomes using YPLLs might underestimate the value of 
NHI HS.  Moreover, although this study used the averted YPLLs as the health 
outcome, considering the aging population problem in Korea, various health 
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outcome models other than YPLLs might be better suited to provide evidence for 
specific health policies under consideration to address aging issues. 
Second, the NHI HE in this study is calculated by total expenditures on 
medical services and prescription medicines based on the NHIC claim database 
from medical institutions and pharmacies.  Although the NHI is the universal 
health insurance system in Korea, there are many unofficial medical services 
including private health care services and Over the Counter (OTC) medicines 
which are not registered in the NHI policy and these costs were not counted in 
this study.  Also indirect costs like transportation cost from home to hospital and 
opportunity costs like time charge during hospital treatments were not 
considered.  Therefore, the estimates on HE in this study are likely to 
underestimate the real costs of healthcare services.  Moreover, although the 
average NHI HE per 100,000 population in all local communities were used in 
this study, the average cost data for all age stratifications at the community level 
between 2007 and 2012 were not available and not considered in this study.  
Since the incremental cost data between 2007 and 2012 were used in this study, 
the effects of using average cost data across all age stratifications on the value of 
the HS calculation might be limited.  But in the future, if the average cost data for 
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all age stratifications are available at the local community level, it would be 
useful to calculate the value of HS for different age groups at the local 
community level and this might give more exact health policy implications to 
reform the present local healthcare system in Korea. 
Third, since this study is based on a meso level analysis by using the 
communities as analysis units, the validity of the value of the HS model should 
be improved in follow-up studies based on individual patient level data.  Since 
this study was not designed by the experiment study method based on 
individual patient level data, this study might have big limitations regarding 
generalizability.  Especially, the various relationships between the averted YPLLs 
and each health determinant like depression and hypertension should be 
supported based on individual patient level data in order to define their exact 
relationships and avoid the problem of the so called “ecological fallacy”.  But it 
could still be meaningful to establish a meso-level value model in the real health 
care settings as a new frontier of public health policy study.  Based on these 
study results, it might be more useful if more studies and policy actions could be 
focused on finding potential relationships between health outcomes and 
determinants of health based on individual level panel data in the future, and 
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highlight the outcome gaps and disparities among local communities in the 
country specific health care context. 
Fourth, although 16 determinants of health were included in the MLR 
models, there might be other determinants of health like the economic growth 
rate, income growth rate, and education level which could affect the value of HS 
or the health outcomes – the averted YPLLs.  And so more determinants of 
health should be considered when those variables are available at the local 
community level in the future.  Since many determinants of health as well as 
NHI HE were recognized to affect the averted YPLLs at the local community 
level in this study, more potential health related factors could be defined and 
their influences should be controlled to obtain more exact study results regarding 
the value of NHI HS.  For example, the incremental increase of YPLLs between 
2007 and 2012 due to suicides in Korea might be influenced by the economic 
downturn in the aftermath of the global financial crisis.  So if we include more 
socio-economic variables in the models, the internal validity and the explanatory 
capabilities could be improved. 
Last but not the least, the study period - 5 years from 2007 to 2012 might 
be short and have certain limitations in measuring the exact value of HS.  Since 
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the real effects of medical services on death would have certain time lags, the 
change of health outcomes in terms of the averted YPLLs by more healthcare 
services could be measured more precisely in the longer time frame.  More 
specifically, the effects of cancer and mental health care on death could be 
realized some years later after the treatments in medical institutions or in the 
community.  So longer time frames should be emphasized and used in future 
follow-up studies.  It might be very useful to follow up on the value of HS at the 
local community level periodically in the future to utilize the value information 
to reform local healthcare systems and optimize the outcomes of local health 




5. 4.  Conclusion 
In conclusion, the NHI HE has increased substantially from 2007 and 2012, 
and the money spent has provided overall fewer premature deaths and a 
positive value of overall HS at the local community level in Korea.  But in the 
case of cancer care, the increased HE for cancer treatment has not provided fewer 
premature deaths at the local community level and the recent policy to increase 
cancer treatment benefits substantially in Korea might have big limitations in 
terms of the averted YPLLs, at least in the relatively short term.  In the case of 
mental health care, the increased HE for mental health care was not associated 
with fewer premature deaths by suicides at the local community level in Korea in 
either 2007 or 2012.  And so it was inferred that more healthcare services in 
cancer and mental health care has not provided fewer premature deaths at the 
local community level in Korea.  We need to continue to track the trends in HE 
and associated health outcomes to ensure that the financial resources under the 
Korea NHI system can be allocated more wisely before we introduce more 
generous benefits for certain NHI HS. 
This study also suggested that in addition to HE there are many predictors 
associated with health outcomes and the value of HS at the local community 
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level.  Although the specific relationships between the determinants of health 
and health outcomes should be supported in follow-up studies based on 
individual patient level panel data, policy makers should consider those various 
determinants of health to reform the present health system toward greater 
efficiency.  More specifically, better and more effective management of biological 
and behavioral health factors at the local community level should be considered 
one of the top priorities in local healthcare reform to increase desirable health 
outcomes. 
Because of new developments in health technology and medicines as well 
as the aging population, most governments globally consider that their 
overburdened health systems should battle to contain their health costs and 
expenditures as well as to maintain health outcomes.  This trend is not an 
exception to Korea.  Specifically, I tried to construct a meso level theoretical 
model for how public health policies and interventions on determinants of health 
can increase the value of HS and health outcomes in the given local community 
health care context and situation, suggesting how to improve value for money 
and efficiency in the local health care system in South Korea.  These meso level 
study results help supplement certain limitations of the country level studies and 
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cross-country level studies on the efficiency of health expenditures which have 
been used broadly, especially in the international organizations like WHO and 
IMF. 
The results of this meso level study also suggest that the national health 
insurance policy with regard to better coverage and higher priced medical 
treatment utilization should be balanced by interventions not only to ensure the 
most efficient health utilization and resource allocation to optimize the health 
care delivery at the local community level, but also to address various 
determinants of health, such as suitable health promotion and prevention 
programs.  Moreover, considering the budget constraints and restrictions to 
adopt new high-priced medical services, and to increase NHI benefits, the 
reallocation of financial resources within the NHI system in order to maximize 
the value of HS and quality of local health care services in the given health care 
situation should be highlighted.   
In this context, more research studies on the relationships between local 
health outcomes and the determinants of health around the reality of local health 
care services under the Korean NHI system should be conducted in the future.  
In addition, more policy efforts should be focused on incentivizing local patients 
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and providers to utilize existing high-priced and inpatient-centered medical 
services like cancer and mental health care more efficiently and utilize more cost-
effective health care services to decrease the burden of deaths as well as HE.  
These efforts will result in financially stable and sustainable efforts, and more 
importantly balanced and equitable health care services under the NHI system in 
Korea as well.  I hope this study can also facilitate the health policy studies on 
the value of health care services at the local community level in the future so that 
policymakers and the public should have an informed picture of the value for 
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Annex 1. Stata Results 
1) Final Model (Overall Health Care) 
 
  
                                                                                 
          _cons    -87299.24   44127.97    -1.98   0.049    -174271.3   -327.1756
    exp_smoking     113.8026   78.75857     1.44   0.150    -41.42314    269.0283
      exp_check    -145.3249   58.16743    -2.50   0.013    -259.9675   -30.68242
      exp_physi    -977.0579   470.5241    -2.08   0.039    -1904.417   -49.69929
    exp_depress    -196.3642   61.10533    -3.21   0.002     -316.797   -75.93137
checkup_done_10     1418.507   608.0465     2.33   0.021     220.1045    2616.909
         ln_los    -2294.301   1119.239    -2.05   0.042    -4500.215   -88.38756
        ln_beds     258.5307   186.6901     1.38   0.168    -109.4179    626.4794
       ln_physi     9383.286   4926.635     1.90   0.058    -326.6462    19093.22
     depression     2041.991   650.5391     3.14   0.002     759.8401    3324.142
        smoke12    -1157.302    829.679    -1.39   0.164    -2792.522    477.9166
         ln_exp     9574.348   4192.553     2.28   0.023     1311.221    17837.48
                                                                                 
         ypll_a        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                 
       Total     531198293   229   2319643.2           Root MSE      =  1377.3
                                                       Adj R-squared =  0.1822
    Residual     413555867   218  1897045.26           R-squared     =  0.2215
       Model     117642426    11    10694766           Prob > F      =  0.0000
                                                       F( 11,   218) =    5.64
      Source         SS       df       MS              Number of obs =     230
> p_smoking




















9.5 10 10.5 11 11.5
ln_exp
lowess ypll_a ln_exp YPLL_A
                                                                                 
          _cons    -91589.54   45893.61    -2.00   0.047    -182046.2   -1132.884
     seoulmetro     260.9906   298.7984     0.87   0.383    -327.9432    849.9244
           city    -205.2533    287.443    -0.71   0.476    -771.8056    361.2991
    exp_smoking     109.0263   80.94048     1.35   0.179    -50.50795    268.5606
      exp_check    -149.2328    61.0693    -2.44   0.015    -269.6008   -28.86476
      exp_physi    -1023.812   474.6037    -2.16   0.032    -1959.259   -88.36413
    exp_depress    -201.2395   61.40514    -3.28   0.001    -322.2695   -80.20948
checkup_done_10     1447.175   638.8606     2.27   0.024     187.9759    2706.374
         ln_los    -1888.868   1189.093    -1.59   0.114    -4232.579    454.8439
        ln_beds     239.1865    188.686     1.27   0.206     -132.715     611.088
       ln_physi      9835.43   4961.956     1.98   0.049     55.37821    19615.48
     depression     2092.529    653.635     3.20   0.002     804.2095    3380.848
        smoke12    -1105.204    852.482    -1.30   0.196    -2785.453     575.044
         ln_exp     9979.283   4366.896     2.29   0.023     1372.099    18586.47
                                                                                 
         ypll_a        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                 
       Total     531198293   229   2319643.2           Root MSE      =  1380.2
                                                       Adj R-squared =  0.1788
    Residual     411442072   216  1904824.41           R-squared     =  0.2254
       Model     119756221    13  9212016.99           Prob > F      =  0.0000
                                                       F( 13,   216) =    4.84
      Source         SS       df       MS              Number of obs =     230
> p_smoking city seoulmetro






                                                                                 
          _cons    -83532.66   44434.74    -1.88   0.061    -171111.6    4046.264
     seoulmetro     228.7566    295.035     0.78   0.439    -352.7446    810.2577
    exp_smoking     102.0908   80.26482     1.27   0.205    -56.10762    260.2893
      exp_check      -138.07   58.96782    -2.34   0.020     -254.293   -21.84696
      exp_physi     -985.911   471.0935    -2.09   0.038    -1914.416   -57.40624
    exp_depress    -199.0098   61.25641    -3.25   0.001    -319.7435   -78.27611
checkup_done_10     1334.165   618.2481     2.16   0.032     115.6254    2552.705
         ln_los    -2122.067   1142.075    -1.86   0.065    -4373.047    128.9132
        ln_beds     256.6862   186.8763     1.37   0.171    -111.6388    625.0112
       ln_physi       9493.3   4933.189     1.92   0.056    -229.7988     19216.4
     depression     2068.879   652.0577     3.17   0.002     783.7014    3354.056
        smoke12    -1033.646   845.6147    -1.22   0.223    -2700.315     633.024
         ln_exp     9201.033   4223.925     2.18   0.030     875.8616     17526.2
                                                                                 
         ypll_a        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                 
       Total     531198293   229   2319643.2           Root MSE      =  1378.6
                                                       Adj R-squared =  0.1807
    Residual     412413323   217  1900522.23           R-squared     =  0.2236
       Model     118784970    12  9898747.48           Prob > F      =  0.0000
                                                       F( 12,   217) =    5.21
      Source         SS       df       MS              Number of obs =     230
> p_smoking seoulmetro
. reg ypll_a ln_exp smoke12 depression ln_physi ln_beds ln_los checkup_done_10 exp_depress exp_physi exp_check ex
                                                                                 
          _cons    -94299.85   45763.58    -2.06   0.041    -184497.9   -4101.842
           city    -167.3221   283.9885    -0.59   0.556     -727.051    392.4069
    exp_smoking     120.8017   79.76629     1.51   0.131     -36.4142    278.0176
      exp_check    -155.2582   60.64529    -2.56   0.011    -274.7874   -35.72902
      exp_physi    -1006.937   473.9513    -2.12   0.035    -1941.075   -72.80024
    exp_depress    -197.8779   61.25094    -3.23   0.001    -318.6009     -77.155
checkup_done_10      1520.32   633.0024     2.40   0.017     272.6999     2767.94
         ln_los    -2123.982   1157.593    -1.83   0.068    -4405.548    157.5841
        ln_beds     244.4768   188.4857     1.30   0.196    -127.0203     615.974
       ln_physi     9649.552   4954.682     1.95   0.053    -115.9091    19415.01
     depression     2058.182   652.0947     3.16   0.002     772.9322    3343.432
        smoke12    -1229.841   839.9957    -1.46   0.145    -2885.436    425.7535
         ln_exp     10251.66   4353.368     2.35   0.019      1671.36    18831.96
                                                                                 
         ypll_a        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                 
       Total     531198293   229   2319643.2           Root MSE      =  1379.4
                                                       Adj R-squared =  0.1797
    Residual     412895348   217  1902743.54           R-squared     =  0.2227
       Model     118302944    12   9858578.7           Prob > F      =  0.0000
                                                       F( 12,   217) =    5.18
      Source         SS       df       MS              Number of obs =     230
> p_smoking city
. reg ypll_a ln_exp smoke12 depression ln_physi ln_beds ln_los checkup_done_10 exp_depress exp_physi exp_check ex
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Seoulmetro Area (n=66) vs. non-Seoulmetro (n=164) 
 
  
                                                                                 
          _cons    -108682.8   83388.22    -1.30   0.194    -273432.4    56066.81
    exp_smoking     26.85602   126.7068     0.21   0.832    -223.4778    277.1898
      exp_check    -146.7652   94.21209    -1.56   0.121    -332.8995    39.36904
      exp_physi    -916.6505   974.8975    -0.94   0.349    -2842.749    1009.449
    exp_depress    -227.7504    94.0907    -2.42   0.017    -413.6448   -41.85594
checkup_done_10     1421.021   1000.672     1.42   0.158    -556.0016    3398.043
         ln_los    -2622.207   1441.529    -1.82   0.071    -5470.227    225.8126
        ln_beds     271.7368   250.4483     1.09   0.280    -223.0723     766.546
       ln_physi     8683.991   10468.12     0.83   0.408    -11997.81    29365.79
     depression     2372.737   1014.103     2.34   0.021     369.1799    4376.294
        smoke12    -208.4488   1357.047    -0.15   0.878    -2889.558     2472.66
         ln_exp     11681.75   7780.096     1.50   0.135    -3689.335    27052.84
                                                                                 
         ypll_a        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                 
       Total     479631826   163  2942526.54           Root MSE      =  1583.6
                                                       Adj R-squared =  0.1478
    Residual     381175024   152  2507730.42           R-squared     =  0.2053
       Model      98456802    11  8950618.36           Prob > F      =  0.0002
                                                       F( 11,   152) =    3.57
      Source         SS       df       MS              Number of obs =     164
> p_smoking if seoulmetro==2
. reg ypll_a ln_exp smoke12 depression ln_physi ln_beds ln_los checkup_done_10 exp_depress exp_physi exp_check ex
                                                                                 
          _cons    -147391.1   50180.27    -2.94   0.005    -247996.5    -46785.7
    exp_smoking     124.7153   99.01588     1.26   0.213    -73.79958    323.2302
      exp_check    -236.3469    76.2034    -3.10   0.003    -389.1255   -83.56828
      exp_physi    -575.7164   484.8132    -1.19   0.240    -1547.708    396.2755
    exp_depress      134.347   88.27626     1.52   0.134    -42.63623    311.3303
checkup_done_10      2437.43   771.3954     3.16   0.003     890.8752    3983.985
         ln_los     2494.529   1778.304     1.40   0.166    -1070.755    6059.813
        ln_beds     359.2113   193.5042     1.86   0.069     -28.7412    747.1637
       ln_physi     5416.952   4935.969     1.10   0.277     -4479.07    15312.97
     depression    -1350.225   905.0075    -1.49   0.142    -3164.655    464.2061
        smoke12    -1331.555   1006.419    -1.32   0.191    -3349.303    686.1932
         ln_exp     14020.05   4996.998     2.81   0.007     4001.671    24038.42
                                                                                 
         ypll_a        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                 
       Total    33925220.5    65   521926.47           Root MSE      =   619.9
                                                       Adj R-squared =  0.2637
    Residual    20750847.3    54   384274.95           R-squared     =  0.3883
       Model    13174373.2    11  1197670.29           Prob > F      =  0.0026
                                                       F( 11,    54) =    3.12
      Source         SS       df       MS              Number of obs =      66
> p_smoking if seoulmetro==1
. reg ypll_a ln_exp smoke12 depression ln_physi ln_beds ln_los checkup_done_10 exp_depress exp_physi exp_check ex
189 
 
City Area (n=145) vs. Rural Area (n=85) 
 . 
                                                                                 
          _cons    -125002.2   185858.7    -0.67   0.503    -495418.1    245413.7
    exp_smoking    -686.4458   393.8522    -1.74   0.086    -1471.392    98.50044
      exp_check     80.12142   239.3315     0.33   0.739    -396.8656    557.1084
      exp_physi    -797.7044   4260.551    -0.19   0.852    -9288.971    7693.562
    exp_depress    -388.0808   175.3805    -2.21   0.030    -737.6137   -38.54786
checkup_done_10     -1092.75    2586.14    -0.42   0.674    -6246.919    4061.419
         ln_los    -4282.391   2484.018    -1.72   0.089    -9233.033    668.2502
        ln_beds      338.939   367.1344     0.92   0.359    -392.7589    1070.637
       ln_physi     6637.902   46433.35     0.14   0.887    -85903.64    99179.44
     depression     4142.476   1910.861     2.17   0.033     334.1357    7950.817
        smoke12     7612.892   4300.756     1.77   0.081    -958.5032    16184.29
         ln_exp     13637.25      17135     0.80   0.429    -20512.76    47787.26
                                                                                 
         ypll_a        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                 
       Total     379092263    84  4513003.13           Root MSE      =  1982.8
                                                       Adj R-squared =  0.1289
    Residual     286990289    73  3931373.83           R-squared     =  0.2430
       Model    92101973.5    11  8372906.69           Prob > F      =  0.0283
                                                       F( 11,    73) =    2.13
      Source         SS       df       MS              Number of obs =      85
> p_smoking if city==2
. reg ypll_a ln_exp smoke12 depression ln_physi ln_beds ln_los checkup_done_10 exp_depress exp_physi exp_check ex
                                                                                 
          _cons    -76349.16   40344.65    -1.89   0.061    -156149.3    3450.989
    exp_smoking     153.5382   74.97087     2.05   0.043     5.248684    301.8276
      exp_check    -134.7445   55.41175    -2.43   0.016    -244.3468   -25.14224
      exp_physi    -1028.818   325.6341    -3.16   0.002     -1672.91   -384.7263
    exp_depress    -199.3762   66.64015    -2.99   0.003    -331.1878   -67.56454
checkup_done_10     1348.613   563.6121     2.39   0.018     233.8099    2463.416
         ln_los    -1840.607   1094.482    -1.68   0.095    -4005.451    324.2359
        ln_beds      63.3894   196.0128     0.32   0.747    -324.3164    451.0952
       ln_physi     9982.022    3385.72     2.95   0.004     3285.198    16678.85
     depression     2051.416   691.2427     2.97   0.004     684.1642    3418.667
        smoke12    -1587.823   772.8851    -2.05   0.042    -3116.559    -59.0859
         ln_exp     8247.794   3957.309     2.08   0.039     420.3906     16075.2
                                                                                 
         ypll_a        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                                 
       Total     132357064   144  919146.276           Root MSE      =  853.01
                                                       Adj R-squared =  0.2084
    Residual    96773247.7   133  727618.404           R-squared     =  0.2688
       Model      35583816    11  3234892.36           Prob > F      =  0.0000
                                                       F( 11,   133) =    4.45
      Source         SS       df       MS              Number of obs =     145
> p_smoking if city==1
. reg ypll_a ln_exp smoke12 depression ln_physi ln_beds ln_los checkup_done_10 exp_depress exp_physi exp_check ex
190 
 
2)  Final Model (Cancer Care) 
 
 
                                                                              
       _cons     1879.746   587.2082     3.20   0.002     722.3838    3037.107
   exp_dep12     38.38279   16.22556     2.37   0.019     6.402927    70.36266
   exp_hyper    -26.63786    12.1019    -2.20   0.029    -50.49017   -2.785551
     ln_beds     35.29425   21.60771     1.63   0.104    -7.293593    77.88209
   depress12    -277.3401   120.8215    -2.30   0.023     -515.474    -39.2061
      stress     4.393298   2.115029     2.08   0.039     .2246676    8.561928
    diabetes    -13.42361   10.20528    -1.32   0.190    -33.53778    6.690557
hypertension     191.9543   90.55428     2.12   0.035     13.47578    370.4328
     smoke12     8.837853   5.491976     1.61   0.109    -1.986591     19.6623
    ln_exp_c    -263.3059   76.85295    -3.43   0.001    -414.7797   -111.8321
                                                                              
     ypll_5c        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
       Total    9883529.58   226  43732.4318           Root MSE      =  199.45
                                                       Adj R-squared =  0.0903
    Residual    8632641.81   217  39781.7595           R-squared     =  0.1266
       Model    1250887.77     9   138987.53           Prob > F      =  0.0005
                                                       F(  9,   217) =    3.49
      Source         SS       df       MS              Number of obs =     227
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       _cons     1969.934    594.655     3.31   0.001     797.8649    3142.004
  seoulmetro    -33.01323   34.13856    -0.97   0.335    -100.3006    34.27414
   exp_dep12     40.93159   16.44063     2.49   0.014     8.526989    73.33619
   exp_hyper    -26.34395   12.10752    -2.18   0.031    -50.20796   -2.479933
     ln_beds     39.16773     21.979     1.78   0.076    -4.153053    82.48851
   depress12    -298.9896   122.8959    -2.43   0.016    -541.2184   -56.76085
      stress     4.528863   2.119985     2.14   0.034      .350356     8.70737
    diabetes     -12.0186    10.3097    -1.17   0.245     -32.3391    8.301889
hypertension     189.0579   90.61732     2.09   0.038     10.45046    367.6653
     smoke12      9.07769   5.498393     1.65   0.100    -1.759683    19.91506
    ln_exp_c    -268.0803   77.02283    -3.48   0.001    -419.8929   -116.2677
                                                                              
     ypll_5c        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
       Total    9883529.58   226  43732.4318           Root MSE      =  199.48
                                                       Adj R-squared =  0.0901
    Residual    8595428.42   216  39793.6501           R-squared     =  0.1303
       Model    1288101.16    10  128810.116           Prob > F      =  0.0007
                                                       F( 10,   216) =    3.24
      Source         SS       df       MS              Number of obs =     227
. reg ypll_5c ln_exp_c smoke12 hypertension diabetes stress depress12 ln_beds exp_hyper exp_dep12 seoulmetro
                                                                              
       _cons     1865.288   588.0556     3.17   0.002     706.2258     3024.35
        city     24.13275   31.28402     0.77   0.441    -37.52829    85.79379
   exp_dep12     37.51527   16.27961     2.30   0.022     5.428042     69.6025
   exp_hyper    -25.99292   12.14202    -2.14   0.033    -49.92494   -2.060906
     ln_beds       39.142   22.19562     1.76   0.079    -4.605729    82.88974
   depress12    -269.2512   121.3882    -2.22   0.028    -508.5082   -29.99415
      stress     4.483865   2.120258     2.11   0.036     .3048199     8.66291
    diabetes    -12.57788   10.27349    -1.22   0.222      -32.827    7.671242
hypertension     187.4078    90.8303     2.06   0.040     8.380624     366.435
     smoke12     8.077957   5.584672     1.45   0.150    -2.929473    19.08539
    ln_exp_c    -265.3857   76.97199    -3.45   0.001    -417.0981   -113.6733
                                                                              
     ypll_5c        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
       Total    9883529.58   226  43732.4318           Root MSE      =  199.64
                                                       Adj R-squared =  0.0886
    Residual     8608924.6   216  39856.1324           R-squared     =  0.1290
       Model    1274604.98    10  127460.498           Prob > F      =  0.0007
                                                       F( 10,   216) =    3.20
      Source         SS       df       MS              Number of obs =     227
. reg ypll_5c ln_exp_c smoke12 hypertension diabetes stress depress12 ln_beds exp_hyper exp_dep12 city
                                                                              
       _cons     1982.478   594.3676     3.34   0.001     810.9439    3154.011
  seoulmetro    -45.77938   35.92831    -1.27   0.204    -116.5962    25.03744
        city      37.2776    32.8983     1.13   0.258     -27.5669    102.1221
   exp_dep12     40.57715   16.43281     2.47   0.014     8.187113    72.96719
   exp_hyper    -25.23406   12.13915    -2.08   0.039    -49.16105   -1.307074
     ln_beds     46.60918   22.92534     2.03   0.043     1.421985    91.79638
   depress12    -294.8666   122.8691    -2.40   0.017    -537.0489   -52.68434
      stress     4.721184   2.125381     2.22   0.027     .5319321    8.910436
    diabetes    -10.16889   10.43145    -0.97   0.331    -30.72989    10.39211
hypertension     180.9149   90.84251     1.99   0.048     1.858986    359.9709
     smoke12     7.996631   5.576994     1.43   0.153    -2.995953    18.98922
    ln_exp_c    -273.1391   77.10162    -3.54   0.000     -425.111   -121.1673
                                                                              
     ypll_5c        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
       Total    9883529.58   226  43732.4318           Root MSE      =  199.35
                                                       Adj R-squared =  0.0913
    Residual    8544402.35   215  39741.4063           R-squared     =  0.1355
       Model    1339127.23    11  121738.839           Prob > F      =  0.0008
                                                       F( 11,   215) =    3.06
      Source         SS       df       MS              Number of obs =     227
. reg ypll_5c ln_exp_c smoke12 hypertension diabetes stress depress12 ln_beds exp_hyper exp_dep12 city seoulmetro
192 
 
Seoulmetro Area (n=66) vs. non-Seoulmetro (n=164) 
 
  
                                                                              
       _cons     1740.328   770.1954     2.26   0.025      218.577    3262.079
   exp_dep12     40.34815   21.35011     1.89   0.061    -1.835379    82.53169
   exp_hyper    -15.53845   19.79938    -0.78   0.434    -54.65805    23.58115
     ln_beds     39.83664    29.2139     1.36   0.175    -17.88416    97.55743
   depress12    -292.1619   159.8622    -1.83   0.070    -608.0174    23.69355
      stress     5.599805   2.653134     2.11   0.036      .357746    10.84186
    diabetes    -10.60447   13.36624    -0.79   0.429    -37.01347    15.80454
hypertension     104.3586   151.1272     0.69   0.491    -194.2384    402.9556
     smoke12     7.598784    7.33564     1.04   0.302    -6.894966    22.09253
    ln_exp_c    -244.0698   100.3089    -2.43   0.016    -442.2601   -45.87951
                                                                              
     ypll_5c        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
       Total    8546340.51   160  53414.6282           Root MSE      =  222.81
                                                       Adj R-squared =  0.0706
    Residual    7496491.87   151  49645.6415           R-squared     =  0.1228
       Model    1049848.64     9  116649.849           Prob > F      =  0.0165
                                                       F(  9,   151) =    2.35
      Source         SS       df       MS              Number of obs =     161
> = 2
. reg ypll_5c ln_exp_c smoke12 hypertension diabetes stress depress12 ln_beds exp_hyper exp_dep12 if seoulmetro =
                                                                              
       _cons     1204.536     1343.1     0.90   0.374    -1486.017     3895.09
   exp_dep12     27.16113   33.17685     0.82   0.416    -39.30008    93.62235
   exp_hyper    -28.96673   15.36853    -1.88   0.065    -59.75359    1.820127
     ln_beds     6.551359   33.44528     0.20   0.845    -60.44759    73.55031
   depress12      -205.33   244.3462    -0.84   0.404    -694.8142    284.1542
      stress     .9218024   3.591361     0.26   0.798    -6.272558    8.116163
    diabetes     -11.2281   14.31278    -0.78   0.436    -39.90003    17.44384
hypertension     213.6345   110.6622     1.93   0.059    -8.048563    435.3175
     smoke12     16.73398   7.931475     2.11   0.039     .8453299    32.62264
    ln_exp_c    -176.5352   180.0669    -0.98   0.331    -537.2525    184.1822
                                                                              
     ypll_5c        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
       Total    1320540.04    65  20316.0006           Root MSE      =  133.86
                                                       Adj R-squared =  0.1180
    Residual    1003498.04    56  17919.6078           R-squared     =  0.2401
       Model    317042.004     9  35226.8893           Prob > F      =  0.0609
                                                       F(  9,    56) =    1.97
      Source         SS       df       MS              Number of obs =      66
> = 1
. reg ypll_5c ln_exp_c smoke12 hypertension diabetes stress depress12 ln_beds exp_hyper exp_dep12 if seoulmetro =
193 
 





                                                                              
       _cons     3877.978   1601.108     2.42   0.018     686.9749    7068.981
   exp_dep12     116.4153   40.07555     2.90   0.005     36.54487    196.2858
   exp_hyper    -43.56894   44.14933    -0.99   0.327    -131.5584    44.42056
     ln_beds     66.56061   43.79447     1.52   0.133    -20.72164    153.8429
   depress12     -871.557   304.9434    -2.86   0.006    -1479.308   -263.8056
      stress     7.599059   3.974134     1.91   0.060    -.3213792     15.5195
    diabetes    -34.35555   21.33883    -1.61   0.112    -76.88377    8.172675
hypertension     329.4409    342.981     0.96   0.340    -354.1193    1013.001
     smoke12     15.44358   12.12914     1.27   0.207    -8.729767    39.61692
    ln_exp_c    -556.4524   204.9418    -2.72   0.008    -964.9009    -148.004
                                                                              
     ypll_5c        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
       Total    7185826.31    82  87632.0282           Root MSE      =   270.4
                                                       Adj R-squared =  0.1657
    Residual    5337362.56    73  73114.5557           R-squared     =  0.2572
       Model    1848463.75     9  205384.861           Prob > F      =  0.0069
                                                       F(  9,    73) =    2.81
      Source         SS       df       MS              Number of obs =      83
. reg ypll_5c ln_exp_c smoke12 hypertension diabetes stress depress12 ln_beds exp_hyper exp_dep12 if city == 2
                                                                              
       _cons     660.8039   588.8947     1.12   0.264    -503.9272    1825.535
   exp_dep12    -7.932112    16.1417    -0.49   0.624    -39.85758    23.99336
   exp_hyper    -25.33485   10.47004    -2.42   0.017    -46.04276   -4.626937
     ln_beds     28.85471   22.12799     1.30   0.194     -14.9106    72.62003
   depress12     60.09045    118.986     0.51   0.614    -175.2432    295.4241
      stress     .6429127   2.199044     0.29   0.770    -3.706413    4.992238
    diabetes     9.704392   9.327651     1.04   0.300    -8.744077    28.15286
hypertension     182.7469    76.5739     2.39   0.018     31.29711    334.1968
     smoke12     4.884559   5.037532     0.97   0.334    -5.078802    14.84792
    ln_exp_c    -77.85567   80.72542    -0.96   0.337    -237.5165    81.80515
                                                                              
     ypll_5c        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
       Total    2676521.27   143  18716.9319           Root MSE      =  134.69
                                                       Adj R-squared =  0.0307
    Residual    2431106.58   134  18142.5864           R-squared     =  0.0917
       Model    245414.692     9  27268.2991           Prob > F      =  0.1530
                                                       F(  9,   134) =    1.50
      Source         SS       df       MS              Number of obs =     144
. reg ypll_5c ln_exp_c smoke12 hypertension diabetes stress depress12 ln_beds exp_hyper exp_dep12 if city == 1
194 
 
3) STATA results (Mental Health Care) 
 
  
                                                                              
       _cons    -237.1126   381.2604    -0.62   0.535    -988.4468    514.2215
    stress12     6.274681   4.712095     1.33   0.184    -3.011253    15.56061
    diabetes      9.07099   14.00468     0.65   0.518    -18.52746    36.66944
hypertension     4.372449   9.066983     0.48   0.630    -13.49548    22.24038
     obecity     8.132563   5.758777     1.41   0.159    -3.216022    19.48115
     beds_11     4.103158   2.890364     1.42   0.157    -1.592764     9.79908
    ln_exp_m     11.55401   40.01175     0.29   0.773     -67.2955    90.40352
                                                                              
      ypll_s        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
       Total    17936762.9   229  78326.4754           Root MSE      =   278.3
                                                       Adj R-squared =  0.0112
    Residual    17271334.4   223    77449.93           R-squared     =  0.0371
       Model     665428.46     6  110904.743           Prob > F      =  0.2034
                                                       F(  6,   223) =    1.43
      Source         SS       df       MS              Number of obs =     230
. reg ypll_s ln_exp_m beds_11 obecity hypertension diabetes stress12
                                                                              
       _cons     42.78717   415.8957     0.10   0.918    -777.1011    862.6754
    ln_equip    -43.17546   19.53483    -2.21   0.028    -81.68603   -4.664894
    stress12     8.802321    4.83622     1.82   0.070    -.7317036    18.33635
    diabetes     16.54679   14.24935     1.16   0.247    -11.54408    44.63767
hypertension     3.549164   9.183051     0.39   0.700    -14.55411    21.65244
     obecity     7.443003   5.801553     1.28   0.201    -3.994059    18.88006
     beds_11     5.897705   3.118029     1.89   0.060    -.2491126    12.04452
    ln_exp_m    -23.73652   44.77657    -0.53   0.597    -112.0081    64.53509
                                                                              
      ypll_s        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                              
       Total    16646296.8   216  77066.1891           Root MSE      =  273.55
                                                       Adj R-squared =  0.0290
    Residual    15639517.3   209  74830.2261           R-squared     =  0.0605
       Model    1006779.58     7  143825.655           Prob > F      =  0.0675
                                                       F(  7,   209) =    1.92
      Source         SS       df       MS              Number of obs =     217
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        _cons     -486.736   607.3515    -0.80   0.423    -1680.298    706.8259
       female    -6.379495    12.0015    -0.53   0.595    -29.96474    17.20575
         city     104.8386      28.53     3.67   0.000     48.77173    160.9056
         year    -12.66498   34.15584    -0.37   0.711    -79.78774    54.45777
      obesity     8.975681   4.193622     2.14   0.033     .7344101    17.21695
      smoking     11.65913   4.219255     2.76   0.006     3.367487    19.95078
ln_exp_mental     105.3287   32.19005     3.27   0.001     42.06909    168.5883
                                                                               
      suicide        Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval]
                                                                               
       Total    30121450.7   461  65339.3725           Root MSE      =  234.82
                                                       Adj R-squared =  0.1561
    Residual    25089068.7   455  55140.8104           R-squared     =  0.1671
       Model    5032381.99     6  838730.332           Prob > F      =  0.0000
                                                       F(  6,   455) =   15.21
      Source         SS       df       MS              Number of obs =     462
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May 13 – Present MINISTRY OF STRATEGY AND FINANCE (MOSF), Korea 
   Director, International Tax Division 
- Plan and coordinate International Tax Policy and Tax Laws in Korea 
 
May 10 – May 13 World Bank Institute, the World Bank  
   Senior Public Sector Specialist, Growth and Competitiveness Unit 
- Planned and coordinated inclusive development policy programs 
 
 
June 09 – May 10 MINISTRY OF STRATEGY AND FINANCE (MOSF), Korea 
   Head, Human Resources Management Team 
- Planned and coordinated MOSF’s HR management and development  
 
 
June 08 – May 09 Presidential Committee on Regional Development, Korea 
   Director, Policy and Planning Division 
- Planned and coordinated Regional Innovation System and Strategy 
- Planned and coordinated Local Finance System 
 
 
Jan 05 – Jun 06 MINISTRY OF PLANNING AND BUDGET (MPB), Korea 
   Senior Deputy Director, Organizational Innovation & Personnel Div. 
- Planned and coordinated MPB’s innovation and restructuring 
- Planned and managed the “Best Place to Work” project 
 
 
Mar 04 – Jan 05 MINISTRY OF PLANNING AND BUDGET, Korea 
   Senior Deputy Director, Education and Culture Budget Division 
- Planned and managed annual education sector budget of FY 2005  including National 
Universities & their Academic Medical Centers  
 
 
Mar 03 – Mar 04 MINISTRY OF PLANNING AND BUDGET, Korea 
   Deputy Director, Social Fiscal Policy Division 
- Planned national agenda and mid-term fiscal expenditure plan for Social safety and 
security sector and regional development 
- Planned and made a Balanced National Development Special Account Act 
 
 
Jun 02 – Mar 03 MINISTRY OF PLANNING AND BUDGET, Korea 
   Deputy Director, Industrial Fiscal Policy Division 
- Planned national agenda and mid-term fiscal expenditure plan for National 




Mar 99 – Jun 02 Korea Air Force Operation Command, Osan AB, Korea 
   Second Lieutenant, the Air Component Command 
- Planned and managed the budget of the Office Automation project 
 
Mar 98 – Mar 99 PRESIDENTIAL PLANNING AND BUDGET COMMISSION 
   Deputy Director, Government Innovation Office 
- Planed measures to innovate public sector entities & enterprises (SOEs) 
 
 
June 96 – Mar 98 MINISTRY OF GOVERNMENT ADMINISTRATION, Korea 
   Deputy Director, Government Innovation Planning Commission 





                                                                             
 
Expected 15  Johns Hopkins University, Bloomberg School of Public Health  
   Doctor of Public Health (DrPH) in Health Policy & Management 
 
May 08   Johns Hopkins University, Bloomberg School of Public Health  
   Master of Health Science (MHS) in Health Finance & Management 
 
Feb 98  SNU, Graduate School of Public Administration (GSPA), Seoul, Korea 
   Master of Public Administration (MPA) 
 
Feb 95  Seoul National University (SNU), Seoul, Korea 





                                                                             
 
HONORS AND AWARDS 
Award of Outstanding Knowledge Management Official from the Minister of Planning and Budget in 
Aug 2005. 
Award of Outstanding Government Official from the Minister of Planning and Budget Commission in 
Dec 1997. 
Award of Outstanding Student from the chairman of Alumni association of GSPA, SNU in Aug 1996. 
Passed the 39
th
 High Level Civil Service Examination for Administration in November 1995. 
Passed the 13
th
 High Level Civil Service Examination for National Assembly in Mar 1995. 
 
PUBLICATIONS AND POLICY REPORTS 
 “The Medium-Term Fiscal Plan (2002-2004),” Ministry of Planning and Budget, 2002. (Co-author) 
“A STUDY ON THE RESTRUCTURING OF THE MINISTRY OF HEALTH AND WELFARE - with 
emphasis on the readjustment of the government functions”, Masters Thesis, GSPA, Seoul National 
University, 1998 
“Government Innovation”, Government Innovation Planning Commission, 1997. (Co-author) 
